Netlist Inc 10-Q for FY2026 Q3
Netlist Inc (NLST)
About this 10-Q
Netlist Inc filed this 10-Q on November 10, 2026, covering the quarter ended September 26, 2026 (FY2026 Q3).
Headline figures
Quarter ended September 26, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $105.1M
- up 148.9% from $42.23M a year earlier
- Net income
- $85.45M
- compared with a net loss of $7.01M a year earlier
- Diluted EPS
- $0.22
- compared with -$0.02 a year earlier
]
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
For the quarterly period ended
or
For the transition period from _____ to _____
Commission file number:

(Exact name of registrant as specified in its charter)
| | |
| ||
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
| | |
(Address of principal executive offices) | | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ◻ | Accelerated filer ◻ |
Smaller reporting company | |
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 5, 2026, there were
NETLIST, INC. AND SUBSIDIARIES
Form 10-Q
For the Quarter Ended September 26, 2026
TABLE OF CONTENTS
| | | Page | |
3 | ||||
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 31 | |||
44 | ||||
44 | ||||
46 | ||||
46 | ||||
46 | ||||
46 | ||||
46 | ||||
47 | ||||
48 | ||||
50 | ||||
2
PART I. — FINANCIAL INFORMATION
Item 1. | Financial Statements |
NETLIST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value) (Unaudited)
| | | | | | |
| | September 26, | | December 27, | ||
| | 2026 | | 2025 | ||
ASSETS | ||||||
Current assets: | | | | | | |
Cash and cash equivalents | | $ | | | $ | |
Restricted cash | | | | | | |
Accounts receivable, net of allowances of $ | | | | | | |
Inventories | | | | | | |
Prepaid expenses and other current assets | | | | | | |
Total current assets | | | | | | |
Property and equipment, net | | | | | | |
Operating lease right-of-use assets | | | | | | |
Deferred income taxes | | | | | | — |
Other assets | | | | | | |
Total assets | | $ | | | $ | |
| | | | | | |
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||
Current liabilities: | | | | | | |
Accounts payable | | $ | | | $ | |
Revolving line of credit | | | — | | | |
Accrued payroll and related liabilities | | | | | | |
Deferred revenue | | | | | | |
Other current liabilities | | | | | | |
Total current liabilities | | | | | | |
Deferred revenue, noncurrent | | | | | | — |
Operating lease liabilities | | | | | | |
Other liabilities | | | | | | |
Total liabilities | | | | | | |
Commitments and contingencies | | | | | | |
Stockholders' equity (deficit): | | | | | | |
Preferred stock, $ | | | | | ||
Common stock, $ | | | | | | |
Additional paid-in capital | | | | | | |
Accumulated deficit | | | ( | | | ( |
Total stockholders' equity (deficit) | | | | | | ( |
Total liabilities and stockholders' equity (deficit) | | $ | | | $ | |
See accompanying Notes to Condensed Consolidated Financial Statements.
3
NETLIST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts) (Unaudited)
| | | Three Months Ended | | Nine Months Ended | ||||||||
| | | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 | ||||
Net product sales | | | $ | | | $ | | | $ | | | $ | |
License fee | | | | | | | — | | | | | | — |
Net sales | | | | | | | | | | | | $ | |
Cost of sales | | | | | | | | | | | | | |
Gross profit | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | |
Research and development | | | | | | | | | | | | | |
Intellectual property legal fees | | | | | | | | | | | | | |
Selling, general and administrative | | | | | | | | | | | | | |
Total operating expenses | | | | | | | | | | | | | |
Operating income (loss) | | | | | | | ( | | | | | | ( |
Other income, net: | | | | | | | | | | | | | |
Interest income, net | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | | | | |
Total other income, net | | | | | | | | | | | | | |
Income (loss) before income tax benefit | | | | | | | ( | | | | | | ( |
Income tax benefit | | | | ( | | | — | | | ( | | | — |
Net income (loss) | | | $ | | | $ | ( | | $ | | | $ | ( |
| | | | | | | | | | | | | |
Earnings (loss) per share: | | | | | | | | | | | | | |
Basic | | | $ | | | $ | ( | | $ | | | $ | ( |
Diluted | | | $ | | | $ | ( | | $ | | | $ | ( |
Weighted-average common shares outstanding: | | | | | | | | | | | | | |
Basic | | | | | | | | | | | | | |
Diluted | | | | | | | | | | | | | |
See accompanying Notes to the Condensed Consolidated Financial Statements.
4
B
NETLIST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
(In thousands) (Unaudited)
| | | | | | | Additional | | | | | Total | ||
| | Common Stock | | Paid-in | | Accumulated | | Stockholders' | ||||||
| | Shares | | Amount | | Capital | | Deficit | | Equity (Deficit) | ||||
Balance, December 27, 2025 | | | | $ | | | $ | | | $ | ( | | $ | ( |
Net income | | — | | | — | | | — | | | | | | |
Exercise of stock options | | | | | — | | | | | | — | | | |
Exercise of warrants | | | | | | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | | | | ( | | | — | | | — |
Balance, March 28, 2026 | | | | | | | | | | ( | | | | |
Net income | | — | | | — | | | — | | | | | | |
Exercise of stock options | | | | | — | | | | | | — | | | |
Exercise of warrants | | | | | | | | | | | | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | | | | ( | | | — | | | — |
Balance, June 27, 2026 | | | | | | | | | | ( | | | | |
Net income | | — | | | — | | | — | | | | | | |
Issuance of common stock, net | | | | | | | | | | | — | | | |
Exercise of stock options | | | | | — | | | | | | — | | | |
Exercise of warrants | | | | | | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | — | | | — | | | — | | | — |
Balance, September 26, 2026 | | | | $ | | $ | | | $ | ( | | $ | | |
See accompanying Notes to the Condensed Consolidated Financial Statements.
5
NETLIST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
(In thousands) (Unaudited) (Continued)
| | | | | | | Additional | | | | | Total | ||
| | Common Stock | | Paid-in | | Accumulated | | Stockholders' | ||||||
| | Shares | | Amount | | Capital | | Deficit | | Deficit | ||||
Balance, December 28, 2024 | | | | $ | | | $ | | | $ | ( | | $ | ( |
Net loss | | — | | | — | | | — | | | ( | | | ( |
Issuance of common stock, net | | | | | | | | | | | — | | | |
Exercise of stock options | | | | | — | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | | | | ( | | | — | | | — |
Tax withholdings related to net share settlements of equity awards | | ( | | | ( | | | ( | | | — | | | ( |
Balance, March 29, 2025 | | | | | | | | | | ( | | | ( | |
Net loss | | — | | | — | | | — | | | ( | | | ( |
Issuance of common stock, net | | | | | | | | | | | — | | | |
Exercise of stock options | | | | | | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | — | | | — | | | — | | | — |
Balance, June 28, 2025 | | | | | | | | | | | ( | | | ( |
Net loss | | — | | | — | | | — | | | ( | | | ( |
Issuance of common stock, net | | — | | | — | | | ( | | | — | | | ( |
Exercise of stock options | | | | | — | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | | | | — | | | |
Restricted stock units vested and distributed | | | | | — | | | — | | | — | | | — |
Balance, September 27, 2025 | | | | $ | | $ | | | $ | ( | | $ | ( | |
See accompanying Notes to the Condensed Consolidated Financial Statements.
6
NETLIST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited)
| | | Nine Months Ended | ||||
| | | September 26, | | September 27, | ||
| | | 2026 | | 2025 | ||
Cash flows from operating activities: | | | | | | | |
Net income (loss) | | | $ | | | $ | ( |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | | | | | |
Depreciation and amortization | | | | | | | |
Non-cash lease expense | | | | | | | |
Gain on forgiveness of payables | | | | ( | | | ( |
Stock-based compensation | | | | | | | |
Deferred income taxes | | | | ( | | | — |
Changes in operating assets and liabilities: | | | | | | | |
Accounts receivable | | | | ( | | | ( |
Inventories | | | | ( | | | ( |
Prepaid expenses and other assets | | | | | | | ( |
Accounts payable | | | | | | | ( |
Accrued payroll and related liabilities | | | | | | | |
Deferred revenue | | | | | | | |
Other liabilities | | | | ( | | | ( |
Net cash provided by (used in) operating activities | | | | | | | ( |
Cash flows from investing activities: | | | | | | | |
Acquisition of property and equipment | | | | ( | | | ( |
Net cash used in investing activities | | | | ( | | | ( |
Cash flows from financing activities: | | | | | | | |
Net borrowings (repayments) under line of credit | | | | ( | | | |
Payments on notes payable | | | | ( | | | ( |
Proceeds from issuance of common stock, net | | | | | | | |
Proceeds from exercise of stock options and warrants | | | | | | | |
Payments for taxes related to net share settlement of equity awards | | | | — | | | ( |
Net cash provided by financing activities | | | | | | | |
Net change in cash, cash equivalents and restricted cash | | | | | | | ( |
Cash, cash equivalents and restricted cash at beginning of period | | | | | | | |
Cash, cash equivalents and restricted cash at end of period | | | $ | | | $ | |
| | | | | | | |
Reconciliation of cash, cash equivalents and restricted cash at end of period: | | | | | | | |
Cash and cash equivalents | | | $ | | | $ | |
Restricted cash | | | | | | | |
Cash, cash equivalents and restricted cash at end of period | | | $ | | | $ | |
See accompanying Notes to the Condensed Consolidated Financial Statements.
7
NETLIST, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1—Summary of Significant Accounting Policies
Basis of Presentation
Our unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain information and footnote disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto as of and for the year ended December 27, 2025, included in our Annual Report on Form 10-K filed with the SEC on March 19, 2026.
In the opinion of management, all adjustments for the fair presentation of our condensed consolidated financial statements have been made. The adjustments are of a normal recurring nature except as otherwise noted. The results of operations for the interim periods are not necessarily indicative of the results to be expected for other periods or the full fiscal year. We have evaluated events occurring subsequent to September 26, 2026 through the filing date of this Quarterly Report on Form 10-Q and concluded that there were no events that required recognition and disclosures other than those discussed elsewhere in the notes hereto.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of Netlist, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Fiscal Year
Our fiscal year is the
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of inventory reserves, allowance for doubtful accounts, the discount rate used for lease obligation, the fair value of performance stock units and the probability of achieving the applicable performance conditions, valuation allowances on deferred income tax assets, and, under our intellectual property license agreement, the identification of performance obligations, the timing of their satisfaction and estimates of variable consideration, including the constraint on variable consideration, and the grant-date fair value of common stock issued to a supplier, including the discount for lack of marketability for post-vesting transfer restrictions. Actual results may differ materially from those estimates.
8
Revenue Recognition
Our significant accounting policies remain consistent with those disclosed in our Annual Report on Form 10-K for the year ended December 27, 2025, except as described below.
Intellectual Property License and Royalty Revenue
During the third quarter of 2026, we entered into a
Our intellectual property license and royalty revenue is comprised of licenses which provide Samsung the right to access our portfolio of patents, including patents added to the portfolio during the license term, in exchange for license fees and sales-based royalties. License fee revenue is recognized on a straight-line basis over the license term. Royalty revenue is recognized in the fiscal quarter to which the royalty relates. License fees and royalties are recognized gross of foreign withholding taxes paid by Samsung on our behalf, which are recorded as an income tax asset until utilized.
Performance Obligations
Our intellectual property license and royalty revenue includes a single performance obligation to provide Samsung with the right to access our patent portfolio, including patents added to the portfolio during the license term, which is satisfied over time. We use a time-elapsed measure of progress because the licensing rights are made available to the customer evenly throughout the license term.
Royalties are variable consideration based on Samsung’s reported revenue and are recognized in accordance with the sales-based royalty guidance under ASC Topic 606, Revenue from Contracts with Customers, in the calendar quarter to which the royalty relates. We have elected the optional exemption not to include sales-based royalties in the remaining performance obligation disclosed under Contract Assets and Liabilities below; these royalties will be determined quarterly over the remaining license term through July 2031. The remaining performance obligation also excludes variable consideration that is constrained, as described under Variable Consideration below.
Variable Consideration
Our licensing agreement includes variable consideration that is contingent upon events occurring in the later periods of the contract. We include variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the related matters are resolved. We reassess the estimate of variable consideration at each reporting date. Changes to our estimate of variable consideration are accounted for as changes in the transaction price. Based on our current estimates, no variable consideration was excluded from the transaction price.
9
Contract Assets and Liabilities
We continually evaluate whether the revenue generating activities and advanced payment arrangements with customers result in the recognition of contract assets or liabilities. Generally, we do not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities (deferred revenues) are comprised of payments received from our customers in advance of transferring products to customers and upfront license fees received in advance of satisfying our license performance obligation over the license term.
As of September 26, 2026 and December 27, 2025, deferred revenue was $
During the three and nine months ended September 26, 2026, we recognized $
We capitalize incremental costs of obtaining contracts with customers when such costs are expected to be recovered. These costs include contingent legal fees that would not have been incurred if the related contracts had not been obtained. Legal fees and other costs that do not qualify for capitalization are expensed as incurred.
Capitalized contract acquisition costs are amortized on a systematic basis consistent with the transfer of the goods or services to which the costs relate and are evaluated for impairment in accordance with ASC 340-40.
In connection with our license agreement with Samsung, we capitalized contingent legal fees that represent incremental costs of obtaining the agreement and are expected to be recovered through the consideration received under the agreement. These costs are being amortized on a straight-line basis over the 20-quarter license term, consistent with the recognition of the related license revenue.
As of September 26, 2026, capitalized contract acquisition costs totaled approximately $
Prepaid Vendor Nonrefundable Deposit
Equity instruments issued to suppliers for goods or services are accounted for under ASC 718, Compensation—Stock Compensation. When the supplier is also a customer or customer affiliate, we apply the consideration payable to a customer guidance in ASC 606. The grant-date fair value of common stock subject to post-vesting transfer restrictions reflects a discount for lack of marketability.
Advance payments for contractual rights to access supplier products are recorded as prepaid vendor nonrefundable deposit assets and recognized in cost of sales on a straight-line basis over the contract term. Amounts expected to be recognized within 12 months are classified as prepaid expenses and other current assets, with the remainder classified as other assets. Recoverability is assessed at each reporting date, and any unamortized balance is recognized in cost of sales upon early termination of the supply arrangement.
10
Recently Issued Accounting Standards
In November 2024, the Financial Accounting Standards Board issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which updates expense disclosure requirements on an annual and interim basis. This ASU is effective for the annual periods beginning after December 15, 2026, and the interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU.
In May 2025, the Financial Accounting Standards Board issued ASU 2025-04, Compensation – Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer, which clarifies accounting for shares, warrants, and other share-based awards an entity grants to its customers. This ASU is effective for the annual periods beginning after December 15, 2026, including interim periods within those annual periods. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU.
Segment Information
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance.
The Company’s chief operating decision maker, the chief executive officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance on a regular basis. Accordingly, the Company considers itself to be
Significant expenses were as follows (in thousands):
| | Three Months Ended | | Nine Months Ended | ||||||||
| | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Expense: | | | | | | | | | | | | |
Employee Compensation (1) | | $ | | | $ | | | $ | | | $ | |
Stock-Based Compensation | | | | | | | | | | | | |
Program Expenses (2) | | | | | | | | | | | | |
Professional Fees (3) | | | | | | | | | | | | |
| (1) | The amounts consisted of employee compensation related to both cost of goods sold (“COGS”) and operating expenses. The amounts do not include stock-based compensation. The amounts do not include professional fees. |
| (2) | The amounts consisted of costs, such as outside services, depreciation, and dues and subscriptions, related to both COGS and operating expenses. The amounts do not include professional fees. |
| (3) | The amounts consisted of legal fees, tax and audit fees. |
11
Note 2—Supplemental Financial Information
Inventories
Inventories consisted of the following (in thousands):
| | September 26, | | December 27, | ||
| | 2026 | | 2025 | ||
Raw materials | | $ | | | $ | |
Work in process | | | | | | |
Finished goods | | | | | | |
| | $ | | | $ | |
Cash Flow Information
The following table shows supplemental disclosures of cash flow information and non-cash financing activities (in thousands):
| | Nine Months Ended | ||||
| | September 26, | | September 27, | ||
| | 2026 | | 2025 | ||
Supplemental disclosure of cash flow information: | | | | | | |
Cash paid during the year for: | | | | | | |
Interest | | $ | | | $ | |
Supplemental disclosure of non-cash investing and financing activities: | | | | | | |
Debt financing of insurance | | $ | | | $ | |
Lease modification to increase operating lease assets | | $ | | | $ | — |
Contract acquisition costs capitalized but not yet paid | | $ | | | $ | — |
Common stock issued in exchange for a prepaid vendor nonrefundable deposit in connection with a supply agreement | $ | | | $ | — | |
Earnings (Loss) Per Share
The following table shows the computation of basic and diluted earnings (loss) per share of common stock (in thousands, except per share data):
| | | Three Months Ended | | Nine Months Ended | ||||||||
| | | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 | ||||
Numerator: Net income (loss) | | | $ | | | $ | ( | | $ | | | $ | ( |
| | | | | | | | | | | | | |
Denominator: | | | | | | | | | | | | | |
Weighted-average basic shares outstanding | | | | | | | | | | | | | |
Effect of dilutive securities | | | | | | | — | | | | | | — |
Weighted-average diluted shares | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Basic income (loss) per share | | | $ | | | $ | ( | | $ | | | $ | ( |
Diluted income (loss) per share | | | $ | | | $ | ( | | $ | | | $ | ( |
12
The table below shows potentially dilutive weighted average common share equivalents, consisting of shares issuable upon the exercise of outstanding stock options and warrants using the treasury stock method and the shares issuable upon vesting of the restricted stock units (“RSUs”).
| | | Three Months Ended | | Nine Months Ended | ||||||||
| | | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 | ||||
Weighted average common share equivalents | | | | | | | | | | | | | |
For the nine months ended September 26, 2026,
For the three and nine months ended September 26, 2026,
Disaggregation of Net Sales
The following table shows disaggregated net sales by major source (in thousands):
| | Three Months Ended | | Nine Months Ended | ||||||||
| | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Net product sales | | $ | | | $ | | | $ | | | $ | |
License fee | | | | | | — | | | | | | — |
Total net sales | | $ | | | $ | | | $ | | | $ | |
Beginning in the third quarter of 2026, we disaggregate net sales into net product sales and license fee revenue. License fee revenue, which arises under the Samsung License Agreement, beginning in the third quarter of 2026 is recognized over the license term or in the period to which the related quarterly license fee relates, as described in Note 1, and its amount and timing are determined by the terms of the agreement. Net product sales, which consist of resales of third-party memory products and sales of our modular memory subsystems, are recognized at a point in time upon transfer of control to the customer and are similarly affected by memory supply, demand and pricing conditions. Accordingly, we no longer present resales of third-party products and sales of our modular memory subsystems as separate categories. Prior-period amounts have been reclassified to conform to the current-period presentation. These reclassifications had no effect on previously reported net sales, net income (loss) or stockholders' equity (deficit).
13
Net sales by country presented below are based on the billing location of the customer (in thousands):
| | Three Months Ended | | Nine Months Ended | ||||||||
| | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
United States | | $ | | | $ | | | $ | | | $ | |
People's Republic of China (1) | | | | | | | | | | | | |
Malaysia | | | | | | | | | | | | |
Republic of Korea | | | | | | — | | | | | | — |
Other countries | | | | | | | | | | | | |
Total net sales | | $ | | | $ | | | $ | | | $ | |
(1) | The People’s Republic of China (“PRC”) includes Hong Kong and Taiwan. |
The United States, PRC, Malaysia, and Republic of Korea accounted for more than
As of December 27, 2025, we had deferred revenue of $
As of September 26, 2026, we had deferred revenue of $
Major Customers, Suppliers and Products
Our net product sales have historically been concentrated in a small number of customers. The following table sets forth the percentage of net product sales made to customers that each comprise 10% or more of total product sales:
| | Three Months Ended | | Nine Months Ended | ||||
| | September 26, | | September 27, | | September 26, | | September 27, |
| | 2026 | | 2025 | | 2026 | | 2025 |
Customer A | | | | | ||||
Customer B | | * | | | * | | * | |
Customer C | | * | | | * | | ||
Customer D | | | * | | | * | ||
Customer E | | | * | | | * | ||
Customer F | | * | | * | | | * | |
* | Less than 10% of net product sales during the period. In addition, license fee revenue under the Samsung License Agreement, all of which was derived from a single licensee, represented approximately |
14
As of September 26, 2026,
Our purchases are typically concentrated in a small number of suppliers. The following table shows the percentage of purchases made from suppliers that each comprise 10% or more of total purchases:
| | Three Months Ended | | Nine Months Ended | ||||
| | September 26, | | September 27, | | September 26, | | September 27, |
| | 2026 | | 2025 | | 2026 | | 2025 |
Supplier A | | | | | ||||
Supplier B | | | * | | * | | * | |
Supplier C | | | * | | * | | * | |
* | Less than 10% of purchases during the period. |
While we believe alternative suppliers may be available, our dependence on a small number of suppliers and the lack of any guaranteed sources for the essential components of our products and the components we resell exposes us to several risks, including the inability to obtain an adequate supply of these components, increases in their costs, delivery delays and poor quality. If we cannot obtain these components in the amounts needed on a timely basis and at commercially reasonable prices, we may not be able to develop or introduce new products, we may experience significant increases in our cost of sales if we are forced to procure components from alternative suppliers and are not able to negotiate favorable terms with these suppliers, we may experience interruptions or failures in the delivery of our products, or we may be forced to cease sales of products dependent on the components or resales of the components we resell to customers directly. Any of these events could have a material adverse effect on our business, operating results and financial condition.
On August 4, 2026, we entered into a
As of September 26, 2026, the prepaid supply asset was $
15
Note 3—Financing Arrangements
On November 7, 2023, we entered into a loan and security agreement (as amended to date, the “2023 SVB Credit Agreement”) with Silicon Valley Bank, a division of First Citizens Bank & Trust Company (“SVB”), which provides for a revolving line of credit up to $
As of September 26, 2026, all obligations under the 2023 SVB Credit Agreement were secured by a first priority security interest in our tangible and intangible assets (excluding our intellectual property). The 2023 SVB Credit Agreement subjects us to certain affirmative and negative covenants, including financial covenants with respect to our liquidity and restrictions on the payment of dividends. As of September 26, 2026, we were in compliance with our covenants under the 2023 SVB Credit Agreement.
We have letters of credit issued by SVB under the 2023 SVB Credit Agreement and Citibank, N.A., which are secured by cash and are classified as restricted cash in the condensed consolidated balance sheets. As of September 26, 2026 and December 27, 2025, (i) outstanding letters of credit were $
Note 4—Leases
We have operating and finance leases primarily associated with office and manufacturing facilities and certain equipment. The determination of which discount rate to use when measuring the lease obligation was deemed a significant judgment.
Lease cost and supplemental condensed consolidated cash flow information related to operating and finance leases were as follows (in thousands):
| | Three Months Ended | | Nine Months Ended | ||||||||
| | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Lease cost: | | | | | | | | | | | | |
Operating lease cost | | $ | | | $ | | | $ | | | $ | |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | | | | | | | |
Operating cash flows from operating leases | | $ | | | $ | | | $ | | | $ | |
Lease modification to increase operating lease assets | | $ | — | | $ | — | | $ | | | $ | — |
For each of the three and nine months ended September 26, 2026 and September 27, 2025, finance lease costs and cash flows from finance leases were immaterial.
16
Supplemental condensed consolidated balance sheet information related to leases was as follows (in thousands):
| | September 26, | | December 27, | ||
| | 2026 | | 2025 | ||
Operating Leases | | | | | | |
Operating lease right-of-use assets | | $ | | | $ | |
| $ | | | $ | | |
Operating lease liabilities | | | | | | |
Total operating lease liabilities | | $ | | | $ | |
| | | | | | |
Finance Leases | | | | | | |
Property and equipment, at cost | | $ | | | $ | |
Accumulated depreciation | | | ( | | | ( |
| $ | | | $ | | |
Other current liabilities | | $ | — | | $ | |
| | | | | | |
| $ | — | | $ | | |
The following table includes supplemental information:
| | September 26, | | December 27, | ||
| | 2026 | | 2025 | ||
Weighted Average Remaining Lease Term (in years) | | | | | | |
Operating leases | | | | | ||
Finance leases | | | | | ||
| | | | | | |
Weighted Average Discount Rate | | | | | | |
Operating leases | | | | | ||
Finance leases | | | — | | | |
Maturities of lease liabilities as of September 26, 2026, were as follows (in thousands):
| | Operating | |
Fiscal Year | | Leases | |
2026 | | $ | |
2027 | | | |
2028 | | | |
2029 | | | |
Total lease payments | | | |
Less: imputed interest | | | ( |
Total | | $ | |
On March 4, 2026, we entered into a First Amendment to Lease (the “Lease Amendment”) with University Research Park LLC (the “Landlord”), pursuant to which we and the Landlord agreed to renew the Company’s existing lease dated April 28, 2021 (the “Lease”), relating to our corporate headquarters located at 111 Academy, Suite 100, Irvine, CA 92617.
The Lease Amendment extends the current term of the Lease to December 31, 2029 with no renewal option. The annual base rent starting on January 1, 2027 will be $
17
Note 5—Income Taxes
We recorded income tax benefit of $
Our effective tax rate was (
During the third quarter of 2026, we released $
As of September 26, 2026, we maintained a valuation allowance of $
Note 6—Commitments and Contingencies
Contingent Legal Expenses
Any litigation, regardless of its outcome, is inherently uncertain, involves a significant dedication of resources, including time and capital, and diverts management’s attention from our other activities. As a result, any current or future claims, allegations, or challenges by or against third parties, whether eventually decided in our favor or settled, could materially adversely affect our business, financial condition and results of operations. Additionally, the outcome of pending or future litigation and/or related patent reviews and reexaminations, as well as any delay in their resolution, could affect our ability to continue to sell our products, protect against competition in the current and expected markets for our products or license or otherwise monetize our intellectual property rights in the future.
We retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with our licensing and enforcement activities. These law firms are often paid an additional fee on a percentage of any negotiated fee, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained. During the third quarter and first nine months of 2026 we recognized $
18
Litigation and Challenges to Netlist Patents at the U.S. Patent and Trademark Office (“USPTO”) and the Patent Trial & Appeal Board (“PTAB”)
We are, from time to time, a party to litigation that arises in the normal course of our business operations. We own numerous patents and continue to seek to grow and strengthen our patent portfolio, which covers various aspects of our innovations and includes various claim scopes. We plan to pursue avenues to monetize our intellectual property portfolio, in which we would generate revenue by selling or licensing our technology, and we intend to vigorously enforce our patent rights against alleged infringers of such rights. We dedicate substantial resources to protecting and enforcing our intellectual property rights, including with patent infringement proceedings we file against third parties and defense of our patents against challenges made by way of reexamination and review proceedings at the USPTO and PTAB.
On August 4, 2026, we entered into a term Patent Cross License Agreement (the “Samsung License Agreement”) with Samsung, effective as of July 1, 2026 (the “Effective Date”). Pursuant to the Samsung License Agreement, each party granted the other party a worldwide, non-exclusive, non-transferable, non-sublicensable, royalty-bearing (in the case of Samsung as licensee) or royalty-free (in the case of us as licensee) licenses to certain patents. In consideration of the license under our patents, Samsung paid the Company an upfront license fee of $
On August 4, 2026, we entered into a Settlement and Release Agreement (the “Samsung Settlement Agreement”) effective as of the Effective Date with Samsung. The Samsung Settlement Agreement was entered into in settlement of the pending legal proceedings between us and Samsung identified therein.
On October 5, 2026, we entered into the Micron License Agreement (as defined below) and the Micron Settlement Agreement (as defined below) with Micron Technology, Inc., resolving our pending patent litigations with Micron (as defined below). Pursuant to the Micron Settlement Agreement, the parties will stipulate to dismiss the pending proceedings within the time period set forth in the Micron Settlement Agreement following receipt of the initial amount due to the Company pursuant to the Micron License Agreement. See Note 10 to these condensed consolidated financial statements for additional information.
Samsung Litigation
In connection with the August 4, 2026 settlement between Netlist and Samsung, the parties have jointly dismissed all litigation pending at the U.S. District Courts and the International Trade Commission (“ITC”).
Micron Litigation
In connection with the October 5, 2026 settlement between Netlist and Micron, the parties have jointly moved to dismiss all litigation pending at the U.S. District Courts, the District Court of the Fourth Judicial District of the State of Idaho, Ada County, and the International Trade Commission (“ITC”). See Note 10 to these condensed consolidated financial statements for additional information.
We expect the other activities below to continue for the foreseeable future, with no guarantee that any ongoing or future patent protection or litigation activities will be successful, or that we will be able to monetize our intellectual property portfolio.
19
Google Litigation
On December 4, 2009, Netlist filed a complaint against Google, Inc. in the U.S. District Court for the Northern District of California (Case no. 3:09-cv-05718), for infringement of the ’912 Patent, seeking damages, a finding of willful infringement and enhanced damages pursuant to 35 U.S.C. § 284, an exceptional case finding and reasonable attorneys’ fees pursuant to 35 U.S.C. § 285, and a preliminary and permanent injunction. On October 17, 2022, the Court entered a stipulated order to stay this case until the resolution of the patent infringement suit against Samsung filed on August 1, 2022 in EDTX (Case No. 2:22-cv-00293), including any appeal thereof.
Kingston Litigation
On October 16, 2026, Netlist filed a complaint against Kingston Technology Company, Inc. and Kingston Technology Corporation in the U.S. District Court for the Central District of California, case no. 8:26-cv-03047, for infringement of U.S. Patent Nos. 12,373,366 and 12,762,074, seeking damages, a finding of willful infringement and enhanced damages pursuant to 35 U.S.C. § 284, an exceptional case finding and reasonable attorneys’ fees pursuant to 35 U.S.C. § 285, and equitable relief.
On November 4, 2026, Netlist filed a complaint against Kingston Technology Company, Inc., Kingston Technology Corporation, Kingston Technology Far East Corp., Kingston Technology (Shanghai) Co., Kingston Technology (Shanghai) Co., Ltd., Kingston Digital, Inc., and Kingston Solutions, Inc. (collectively, “Kingston”) in the U.S. District Court for the Central District of California, case no. 8:26-cv-03262, for infringement of U.S. Patent Nos. 10,025,731 (“the ’731 Patent”), 11,200,120 (“the ’120 Patent”), 11,914,481 (“the ’481 Patent”), and 12,675,407 (“the ’407 Patent”), seeking damages, a finding of willful infringement and enhanced damages pursuant to 35 U.S.C. § 284, an exceptional case finding and reasonable attorneys’ fees pursuant to 35 U.S.C. § 285, and equitable relief.
On November 5, 2026, Netlist filed a complaint under Section 337 of the Tariff Act of 1930, as amended (19 U.S.C. § 1337) at the U.S. International Trade Commission (“ITC”), docket no. 337-3946, for patent infringement against Kingston and Lenovo (Beijing) Ltd., Lenovo (United States) Inc., Lenovo Global Technology (United States) Inc., Lenovo Group Ltd., and Lenovo PC HK Ltd. (collectively, “Lenovo”), CDW Corp., CDW Logistics LLC, Ingram Micro, Inc., Insight Direct USA, Inc., Insight Enterprises, Inc., and Zones LLC (collectively, “Respondents”). The complaint alleges infringement of the ’731, ’120, ’481, and ’407 Patents by Kingston’s Double Data Rate 5th Gen. (“DDR5”) Registered Dual Inline Memory Module (“RDIMM”) or solid state drive (“SSD”), products containing the same, and components thereof. Netlist seeks a limited exclusion order and a permanent cease-and-desist order from the ITC to stop Respondents’ infringing acts with respect to these infringing products.
Challenges to Netlist Patents at the USPTO and the PTAB
Although the Samsung Settlement Agreement and the Micron Settlement Agreement resolved our pending disputes with Samsung and Micron, certain proceedings before the USPTO, the PTAB and the CAFC remain pending. Samsung and Micron have withdrawn from the appeals that we filed with the CAFC from adverse PTAB final written decisions, but those appeals, which seek to reverse findings of unpatentability that would otherwise remain in effect as to all third parties, continue. In addition, ex parte reexaminations ordered by the USPTO proceed between the USPTO and the patent owner and are not terminated by a settlement with the requester, and certain reexamination requests were filed by unidentified parties that are not party to either settlement. We intend to continue to pursue these appeals and to defend our patents in these proceedings. The status of each such proceeding is described below.
20
On February 17, 2022, Samsung filed a Petition for IPR of Claim 16 of the ’912 Patent (Case No. IPR2022-00615). On November 18, 2022, Micron also filed a Petition for IPR of Claim 16 of the ’912 Patent, IPR2023-00203. On April 17, 2024, the PTAB issued a final written decision in the
On March 2, 2022, Samsung filed a Petition for IPR of the ’339 Patent (Case No. IPR2022-00639). On November 18, 2022, Micron also filed a Petition for IPR of the ’339 Patent (Case No. IPR2023-00204). On October 18, 2023, the PTAB issued a final written decision in the
On May 17, 2022, Samsung filed a Petition for IPR of the ’918 Patent (Case No. IPR2022-00996). On January 6, 2023, Micron also filed a Petition for IPR of the ’918 Patent, Case No. IPR2023-00406. On December 6, 2023, the PTAB issued a final written decision in the
On May 17, 2022, Samsung filed a Petition for IPR of the ’054 Patent (Case No. IPR2022-00999). On January 6, 2023, Micron also filed a Petition for IPR of the ’054 Patent (Case No. IPR2023-00405). On December 5, 2023, the PTAB issued a final written decision in the
On August 26, 2022, Samsung filed a Petition for IPR of the ’160 Patent (Case No. IPR2022-01427). On May 8, 2023, Micron also filed a Petition for IPR of the ’160 Patent, Case No. IPR2023-00883. On April 1, 2024, the PTAB issued a final written decision in the
On August 26, 2022, Samsung filed a Petition for IPR of the ’060 Patent (Case No. IPR2022-01428). On May 8, 2023, Micron also filed a Petition for IPR of the ’060 Patent (Case No. IPR2023-00882). On April 1, 2024, the PTAB issued a final written decision in the
On January 10, 2023, Samsung filed a Petition for IPR of the ’215 Patent, Case No. IPR2023-00455. On May 8, 2023, Micron also filed a Petition for IPR of the ’215 Patent (Case No. IPR 2023-01142). On July 30, 2024, the PTAB issued a final written decision in the
On January 10, 2023, Samsung filed a Petition for IPR of the ’417 Patent (Case No. IPR2023-00454). On May 8, 2023, Micron also filed a Petition for IPR of the ’417 Patent (Case No. IPR2023-01141). On July 30, 2024, the PTAB issued a final written decision in the
21
On September 9, 2026, the CAFC heard oral arguments on the consolidated appeals of the IPRs of the ’215 and ’417 Patents. In connection with the August 4, 2026 settlement between Netlist and Samsung, Samsung withdrew from these consolidated appeals. In connection with the October 5, 2026 settlement between Netlist and Micron, Micron also withdrew from these consolidated appeals. These consolidated appeals remain pending.
On August 14, 2025, an unidentified party filed a request for Ex Parte Reexamination of the ’608 Patent (Application No. 90/015,449). On October 17, 2025, Netlist filed a petition to the Director to terminate this reexamination. On November 5, 2025, the unidentified party opposed. On November 7, 2025, the request for reexamination was granted by the examiner. On January 6, 2026, Netlist filed a renewed petition to the Director to terminate this reexamination. On January 15, 2026, the unidentified party opposed.
On August 25, 2025, Samsung filed a Petition for Post Grant Review (“PGR”) of the ’087 Patent (Case No. PGR2025-00071) and a Petition for IPR of the ’087 Patent (IPR2025-01402). On February 18, 2026, the PTAB denied institution of the IPR but granted institution of the PGR. On March 4, 2026, Netlist filed a Request for Director Review of the PGR institution decision. In connection with the August 4, 2026 settlement between Netlist and Samsung, the parties jointly dismissed this PGR.
On August 29, 2025, Samsung filed a Petition for IPR of the ’731 Patent (IPR2025-01431). On February 18, 2026, the PTAB granted institution of the IPR. On March 4, 2026, Netlist filed a Request for Director Review of the institution decision. In connection with the August 4, 2026 settlement between Netlist and Samsung, the parties jointly dismissed this IPR.
On March 3, 2026, Samsung filed a request for Ex Parte Reexamination of the ‘035 (Application No. 90/016,022). On April 24, 2026, the USPTO ordered reexamination. On June 16, 2026, Netlist filed a petition for the Director to Suspend & Terminate Reexamination. On June 30, 2026, Samsung filed an opposition to the petition.
On April 3, 2026, Samsung filed a request for Ex Parte Reexamination of the ‘366 (Application No. 90/016,140). The USPTO ordered reexamination on July 1, 2026. On September 15, 2026, Netlist filed a petition for the Director to Suspend & Terminate Reexamination. On June 25, 2026, Micron filed a separate request for Ex Parte Reexamination of the ‘366 (Application No. 90/016,418). On July 27, 2026, Netlist filed a Pre-order Paper (SNQ Brief). On August 11, 2026, Micron filed a Petition Request for Authorization to File a Response to Netlist’s Pre-order Paper. On August 25, 2026, the USPTO dismissed Micron’s petition, and on September 10, 2026, the USPTO denied the request for reexamination.
On September 9, 2026, an unidentified party filed a request for Ex Parte Reexamination of the ’731 Patent (Application No. 90/016,577). On October 9, 2026, Netlist filed a Pre-order Paper (SNQ brief).
German Proceedings
On March 31, 2022, Netlist filed infringement claims against Micron in Dusseldorf, Germany, seeking damages for infringement of European Patents EP 2,454,735 (“EP735”) and EP 3,404,660 (“EP660”). On September 1, 2022, Micron initiated nullity proceedings on the
22
On June 3, 2022, Netlist filed infringement claims against Samsung in Dusseldorf, Germany, seeking damages for infringement of European Patents EP735 and EP660. On September 25, 2023, the Dusseldorf Court stayed the case until the German Federal Patent Court decisions on the nullity proceedings on EP735 and EP660 either become final or are reversed or remanded on appeal. On July 6, 2026, Netlist withdrew its infringement claims on EP735. In connection with the August 4, 2026 settlement between Netlist and Samsung, Netlist also withdrew its infringement claims on EP660.
On July 26, 2022, Netlist filed infringement claims against Google Cloud EMEA Limited, Google Germany GmbH, Redtec Computing GmbH, and Google LLC in Dusseldorf, Germany, seeking damages for infringement of European Patents EP735 and EP660. On March 18, 2024, the Dusseldorf Court stayed the case until the German Federal Patent Court decisions on the nullity proceedings on EP735 and EP660 either become final or are reversed or remanded on appeal. On July 6, 2026, Netlist withdrew its infringement claims on EP735.
In the nullity proceeding on EP735, the German Federal Patent Court issued its reasons of judgment revoking EP735 on April 18, 2024. Netlist filed an appeal on May 13, 2024. An oral hearing at the Federal Court of Justice took place on May 21, 2026, where the Federal Court of Justice issued a final revocation of EP735.
In the nullity proceeding on EP660, the German Federal Patent Court issued its reasons of judgment revoking EP660 on February 18, 2025. Netlist filed an appeal on March 12, 2025. In connection with the August 4, 2026 settlement between Netlist and Samsung, Samsung withdrew from the nullity proceeding on EP660. In connection with the October 5, 2026 settlement between Netlist and Micron, Micron also withdrew from the nullity proceeding on EP660.
Other Contingent Obligations
In the ordinary course of our business, we have made certain indemnities, commitments and guarantees pursuant to which we may be required to make payments in relation to certain transactions. These may include, among others: (i) intellectual property indemnities to our customers and licensees in connection with the use, sale and/or license of our products; (ii) indemnities to vendors and service providers pertaining to claims based on our negligence or willful misconduct; (iii) indemnities involving the accuracy of representations and warranties in certain contracts; (iv) indemnities to our directors and officers to the maximum extent permitted under the laws of the State of Delaware; (v) indemnities pertaining to all obligations, demands, claims, and liabilities claimed or asserted by any other party in connection with transactions contemplated by applicable investment or loan documents, as applicable; (vi) severance and other related obligations; and (vii) indemnities or other claims related to certain real estate leases, under which we may be required to indemnify property owners for environmental and other liabilities or may face other claims arising from our use of the applicable premises. The duration of these indemnities, commitments and guarantees varies and, in certain cases, is indefinite. The majority of these indemnities, commitments and guarantees do not provide for any limitation of the maximum potential for future payments we could be obligated to make. Historically, we have not been obligated to make significant payments as a result of these obligations, and no liabilities have been recorded for these indemnities, commitments and guarantees in the accompanying consolidated balance sheets.
23
Note 7—Stockholders’ Equity
Serial Preferred Stock
Our authorized capital stock includes
On April 17, 2017, we entered into a rights agreement (as amended from time to time, the “Rights Agreement”) with Computershare Trust Company, N.A., as rights agent. In connection with the adoption of the Rights Agreement and pursuant to its terms, the Company’s Board of Directors (the “Board” or “Board of Directors”) authorized and declared a dividend of
On April 17, 2024, we entered into a fourth amendment (the “Fourth Amendment”) to the Rights Agreement, pursuant to which Equiniti Trust Company, LLC was appointed as our rights agent and the definition of “Expiration Date” in the Rights Agreement was amended to extend the term for an additional
Each Right entitles the registered holder, subject to the terms of the Rights Agreement, to purchase from us, when exercisable and subject to adjustment,
In connection with the adoption of the Rights Agreement, the Board approved a Certificate of Designation of the Series A Preferred Stock (the “Certificate of Designation”) designating
Common Stock
On September 24, 2025, our stockholders approved the Certificate of Amendment to the Restated Certificate of Incorporation to increase the number of shares of common stock authorized for issuance from
24
Samsung Securities Purchase Agreement
On August 4, 2026, in connection with and as a condition to the parties’ entry into the SSI Supply Agreement and effective as of July 31, 2026, we entered into a Securities Purchase Agreement (the “Samsung Purchase Agreement”) and a Lock-Up and Release Agreement (the “Samsung Lock-Up and Release Agreement”) with Samsung Semiconductor. Pursuant to the Samsung Purchase Agreement, Samsung Semiconductor purchased
The grant-date fair value of the SSI Shares was measured as of July 31, 2026 based on the quoted market price of our common stock of $
Tranche release date | | Restriction period (years) | | Expected volatility | | Expected dividend yield | | Discount for lack of marketability | | Fair value per share |
First anniversary | | | | | | | $ | |||
Second anniversary | | | | | | | $ | |||
Third anniversary | | | | | | | $ | |||
Fourth anniversary | | | | | | | $ | |||
Fifth anniversary | | | | | | | $ |
The weighted-average grant-date fair value of the SSI Shares was $
Note 8—Stock-Based Awards
On September 9, 2025, our stockholders approved the Netlist, Inc. 2025 Equity Incentive Plan (the “2025 Plan”) at our 2025 Annual Meeting of Stockholders, pursuant to which (i)
25
On July 1, 2026, we adopted the Netlist, Inc. 2026 Performance Equity Plan (the “2026 Plan”). Pursuant to the terms of the 2026 Plan, we may, under the direction of the Board, make grants of stock options, restricted and unrestricted stock awards and other stock-based awards to employees (including current and future executives), consultants and directors. The 2026 Plan was approved by the Board without stockholder approval. On July 16, 2026, the Board granted Chun K. Hong, our President, Chief Executive Officer and Chairperson of our Board, restricted stock units to be settled in
Stock Options
The following table summarizes the activity related to stock options during the nine months ended September 26, 2026:
| | | | | Weighted- | |
| | Number of | | Average | ||
| | Shares | | Exercise | ||
| | (in thousands) | | Price | ||
Outstanding as of December 27, 2025 | | | | | $ | |
Granted | | | — | | | — |
Exercised | | | ( | | | |
Expired or forfeited | | | ( | | | |
Outstanding as of September 26, 2026 | | | | | $ | |
Restricted and Performance Stock Units
The following table summarizes the activity related to RSUs and PSUs during the nine months ended September 26, 2026:
| | | | | Weighted- | |
| | | | | Average | |
| | Number of | | Grant-Date | ||
| | Shares | | Fair Value | ||
| | (in thousands) | | per Share | ||
Balance nonvested as of December 27, 2025 | | | | | $ | |
Granted | | | | | | |
Vested | | | ( | | | |
Forfeited | | | ( | | | |
Balance nonvested as of September 26, 2026 | | | | | $ | |
Chief Executive Officer Performance Equity Award
The RSUs granted to on July 16, 2026 under the 2026 Plan (the "Award") consisted of
The time-based RSUs vest in equal annual installments beginning August 15, 2027.
26
The performance-based RSUs consist of a listing tranche of
The share price and revenue tranches are as follows:
Stock price goal | Number of RSUs | Minimum service period | Grant-date fair value per RSU |
$ | | $ | |
$ | | $ | |
$ | | $ | |
$ | | $ |
Unvested RSUs generally are forfeited upon termination of Mr. Hong's service, subject to specified acceleration or continued-eligibility provisions for death, disability, qualifying termination and change of control. Upon death or disability, time-based RSUs scheduled to vest during the following
The grant-date fair value of the time-based RSUs and listing tranche was determined using the closing price of our common stock on the grant date of $
Grant-date stock price | $ |
Expected volatility | |
Risk-free interest rate | |
Performance period (years) | |
Expected dividend yield |
The aggregate grant-date fair value of the Award was $
Stock-based compensation cost for the Award is measured at grant-date fair value and recognized over the requisite service periods of the applicable awards, net of estimated forfeitures. The time-based RSUs are recognized over the applicable service periods associated with their annual vesting installments. The requisite service periods for the share price and revenue tranches range from approximately
27
We reassess the probability of satisfying each applicable performance condition at each reporting date. Changes in our assessments may result in a cumulative adjustment to compensation expense in the period of the change, with any remaining expense recognized over the applicable remaining requisite service period.
Stock-Based Compensation
The following table summarizes the stock-based compensation expense by line item in the condensed consolidated statements of operations (in thousands):
| | | Three Months Ended | | Nine Months Ended | ||||||||
| | | September 26, | | September 27, | | September 26, | | September 27, | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 | ||||
Cost of sales | | | $ | | | $ | | | $ | | | $ | |
Research and development | | | | | | | | | | | | | |
Selling, general and administrative | | | | | | | | | | | | | |
Total | | | $ | | | $ | | | $ | | | $ | |
As of September 26, 2026, we had approximately $
Note 9—Warrants
Warrant activity for the nine months ended September 26, 2026 is as follows:
| | | | | Weighted | |
| | Number of | | Average | ||
| | Shares | | Exercise | ||
| | (in thousands) | | Price | ||
Outstanding as of December 27, 2025 | | | | | $ | |
Granted | | | — | | | — |
Exercised | | | ( | | | |
Expired | | | — | | | — |
Outstanding as of September 26, 2026 | | | | | $ | |
28
Note 10—Subsequent Events
Micron Settlement Agreement
On October 5, 2026, we entered into a Settlement and Release Agreement (the “Micron Settlement Agreement”) with Micron Technology, Inc., which settles and mutually releases all pending legal proceedings between us and Micron identified therein.
Micron Patent License Agreement
On October 5, 2026, we entered into a Patent License Agreement (the “Micron License Agreement”) with Micron Technology, Inc. Pursuant to the Micron License Agreement, we granted Micron a worldwide, non-exclusive, non-transferable, non-sublicensable
Under the Micron License Agreement, Micron agreed to pay us quarterly license fees of $
Micron Securities Purchase and Lock-Up and Release Agreements
On October 5, 2026, we entered into a Securities Purchase Agreement (the “Micron Purchase Agreement”) and a Lock-Up and Release Agreement (the “Micron Lock-Up and Release Agreement”) with Micron Technology, Inc. Pursuant to the Micron Purchase Agreement, Micron Technology purchased
Transaction and Retention Bonus Letters
On November 6, 2026, the independent members of our Board of Directors, advised by the Board's independent compensation consultant, approved one-time cash bonuses for Chun K. Hong, our President and Chief Executive Officer, and Gail Sasaki, our Executive Vice President and Chief Financial Officer, in recognition of their contributions to our multiyear intellectual property monetization strategy, including the negotiation and execution of the Samsung License Agreement and the Micron License Agreement, and to promote their continued retention. On November 6, 2026, we entered into bonus letters with Mr. Hong and Ms. Sasaki reflecting these awards.
Mr. Hong is eligible to receive a cash retention bonus of $
29
6, 2026, he must repay a pro rata portion of the amounts paid (or, upon a termination for cause, all of those amounts).
Ms. Sasaki will receive a lump-sum cash retention bonus of $
The retention bonuses were approved after September 26, 2026 and, accordingly, no amounts related to them were recognized in the condensed consolidated financial statements for the three and nine months ended September 26, 2026. We expect to recognize compensation expense for the retention bonuses over the applicable service and retention periods, beginning in the fourth quarter of 2026.
The foregoing description of the retention bonus letters is qualified in its entirety by reference to the retention bonus letters for Mr. Hong and Ms. Sasaki, which are filed as Exhibits 10.9 and 10.10, respectively, to this Quarterly Report on Form 10-Q.
30
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Note Regarding Forward-Looking Statements
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) and other parts of this report include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than historical facts and often address future events or our future performance. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “may,” “will,” “might,” “plan,” “predict,” “believe,” “should,” “could” and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
Forward-looking statements contained in this MD&A and the condensed consolidated financial statements and the related notes included in Part I, Item 1 of this report include statements about, among other things:
| ● | our beliefs regarding the market and demand for our products or the component products we resell, including our beliefs regarding memory chip shortages and when new manufacturing facilities may become operational; |
| ● | the outcome of our pending litigation, including our ongoing litigation with Google, Inc. (“Google”) or any other counter parties; |
| ● | our ability to collect amounts owed to us pursuant to the Samsung License Agreement and the Micron License Agreement, the amount of quarterly license fees payable under the revenue-based formula and the effects of any variable consideration, and our dependence on these licensees for a significant portion of our revenue; |
| ● | our beliefs and estimates regarding potential intellectual property suits or claims in process under current litigation; |
| ● | our ability to defend successfully any challenges to our intellectual property or claims asserting patent infringement relating to our products; |
| ● | our ability to develop and launch new products that are attractive to the market and stimulate customer demand for these products; |
| ● | our plans relating to our intellectual property, including our goals of monetizing, protecting, licensing, expanding and defending our patent portfolio; |
| ● | our expectations and strategies regarding outstanding legal proceedings and patent reexaminations relating to our intellectual property portfolio; |
| ● | our expectations with respect to any strategic partnerships or other similar relationships we currently have and may pursue in the future; |
| ● | the competitive landscape of our industry; |
| ● | general market, economic and political conditions; |
| ● | our business strategies and objectives; |
| ● | our expectations regarding our future operations and financial position, including revenues, costs and prospects, and our liquidity and capital resources, including cash flows, sufficiency of cash resources, efforts to reduce expenses and the potential for future financings; |
| ● | our ability to remediate any material weakness and maintain effective internal control over financial reporting; and |
| ● | the impact of the above factors and other future events on the market price and trading volume of our common stock. |
31
All forward-looking statements reflect management’s present assumptions, expectations and beliefs regarding future events and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed in or implied by any forward-looking statements. These risks and uncertainties include those described under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 19, 2026 (the “Annual Report”) and our Quarterly Report on Form 10-Q filed with the SEC on August 11, 2026. In light of these risks and uncertainties, our forward-looking statements should not be relied on as predictions of future events. All forward-looking statements reflect our assumptions, expectations and beliefs only as of the date they are made, and except as required by law, we undertake no obligation to revise or update any forward-looking statements for any reason.
The following MD&A should be read in conjunction with our condensed consolidated financial statements and the related notes included in Part I, Item 1 of this report, as well as our Annual Report. All information presented herein is based on our fiscal calendar, and references to particular years, quarters, months or periods refer to our fiscal years ended in January or December and the associated quarters, months and periods of those fiscal years. Each of the terms the “Company,” “Netlist,” “we,” “us,” or “our” as used herein refers collectively to Netlist, Inc. and its consolidated subsidiaries, unless otherwise stated.
Overview
We are a leading innovator in advanced memory and storage solutions. With a rich portfolio of patented technologies, our inventions are foundational to the advancement of artificial intelligence (“AI”) computing. During the third quarter of 2026, we recorded net sales of $105.1 million, including $44.9 million of license fee revenue under the Samsung License Agreement, gross profit of $68.9 million and a net income of $85.4 million, which reflects an income tax benefit of $44.0 million. During and after the quarter, we resolved our patent litigation with Samsung and Micron through the license and settlement arrangements described under “Recent Developments” below.
Recent Developments
Micron Settlement, Securities Purchase Agreement, and License Agreements
On October 5, 2026, we entered into a Patent License Agreement (the “Micron License Agreement”), Settlement and Release Agreement (the “Micron Settlement Agreement”), Securities Purchase Agreement (the “Micron Purchase Agreement”) and a Lock-Up and Release Agreement (the “Micron Lock-Up and Release Agreement”) with Micron Technology, Inc. (“Micron”). Pursuant to the Micron License Agreement, we granted Micron a worldwide, non-exclusive, non-transferable, non-sublicensable five-year term license to our entire worldwide patent portfolio. Under the Micron License Agreement, Micron agreed to pay us quarterly license fees of $30 million for each of the twenty calendar quarters from the fourth calendar quarter of 2026 through the third calendar quarter of 2031, for a total value of $600 million during the five-year term of the Micron License Agreement.
In conjunction with the Micron License Agreement, Micron purchased 10 million shares of our common stock (the “Micron Shares”) for an aggregate cash purchase price of $1 million pursuant to the Micron Purchase Agreement. The shares are subject to transfer restrictions that lapse over a five-year period. We accounted for the issuance of the Micron Shares as consideration payable to a customer, resulting in a reduction of license revenue of $2.0 million per quarter over the five-year license term. The excess of the fair value of the shares over the purchase price, totaling $39.2 million, was accounted for as consideration payable to a customer and will be recognized as a reduction of license revenue over the five-year license term. Accordingly, we expect to recognize approximately $28.0 million of license revenue per quarter.
Company counsel for the Micron litigation is entitled to receive up to 7.5% of amounts paid pursuant to the Micron License Agreement when such amounts are paid to the Company.
32
Samsung Patent Cross License Agreement
On August 4, 2026, we entered into a five-year term Patent Cross License Agreement (the “Samsung License Agreement”) with Samsung Electronics Co., Ltd., a company existing under the laws of the Republic of Korea (“Samsung”), effective as of July 1, 2026 (the “Effective Date”). Pursuant to the Samsung License Agreement, each party grants the other party a worldwide, non-exclusive, non-transferable, non-sublicensable, royalty-bearing (in the case of Samsung as licensee) or royalty-free (in the case of us as licensee) licenses to certain patents. In consideration of the license under our patents, Samsung paid the Company an upfront license fee of $200 million and agreed to pay quarterly license fees of up to $27.5 million for each of the twenty calendar quarters from the Effective Date through the second calendar quarter of 2031, with the amount of each quarterly license fee payment to be calculated in accordance with a revenue-based formula set forth in the Samsung License Agreement. Under the Samsung License Agreement, Samsung is responsible for all Korean withholding taxes applicable to the license fee payments and is required to gross up such payments so that the Company receives the full stated amounts. As a result, Samsung’s total payment obligation under the Samsung License Agreement, inclusive of estimated Korean withholding taxes payable to the Korean tax authorities, is up to approximately $898.2 million consisting of approximately $239 million in upfront fees and $32.9 million in fees per quarter. We received the upfront license fee in August 2026. We recognized $44.9 million of license fee revenue under the Samsung License Agreement during the third quarter of 2026, and, as of September 26, 2026, $227.5 million of the amounts received was recorded as deferred revenue, of which $47.9 million is expected to be recognized within the next 12 months and the remainder through July 2031. Quarterly license fees are calculated under a revenue-based formula and are subject to certain adjustments based on events that may occur later in the term of the contract; accordingly, the amount of future license fee revenue from Samsung may vary from quarter to quarter.
Company counsel for the Samsung litigation is entitled to receive up to 7.5% of amounts paid pursuant to the Samsung License Agreement when such amounts are paid to the Company.
Samsung Settlement Agreement
On August 4, 2026, we entered into a Settlement and Release Agreement (the “Samsung Settlement Agreement”) effective as of the Effective Date with Samsung. The Samsung Settlement Agreement was entered into in settlement of the pending legal proceedings between us and Samsung identified therein.
Samsung Supply Agreement
On August 4, 2026, we entered into a five-year Supply Agreement (the “SSI Supply Agreement”) with Samsung Semiconductor, Inc. (“Samsung Semiconductor”), effective as of the Effective Date. Pursuant to the SSI Supply Agreement, the Company has the right to purchase from Samsung Semiconductor up to $300 million of DRAM and NAND products each year for an aggregate of up to $1.5 billion during the term of the SSI Supply Agreement on the pricing terms set forth therein.
Samsung ITC Cooperation Agreement
On August 4, 2026, in connection with the Samsung Settlement Agreement, we also entered into an ITC Cooperation Agreement with Samsung with a term of five years during which time Samsung agreed to produce or provide certain information, documents, or declarations to us to use in future International Trade Commission actions against third parties.
33
Samsung Securities Purchase Agreement
On August 4, 2026, in connection with and as a condition to the parties’ entry into the SSI Supply Agreement and effective as of July 31, 2026, we entered into a Securities Purchase Agreement and a Lock-Up and Release Agreement with Samsung Semiconductor. Pursuant to the Securities Purchase Agreement, Samsung Semiconductor purchased 10 million shares (the “SSI Shares”) of our common stock for an aggregate cash purchase price of $1 million. Pursuant to the Lock-Up and Release Agreement, twenty percent of the SSI Shares will be released from the disposition and transfer restrictions set forth therein on each of the first, second, third and fourth anniversaries of the issuance of the SSI Shares, with the remaining SSI Shares released on the fifth anniversary. The issuance of the SSI Shares to Samsung Semiconductor was not registered under the Securities Act of 1933, as amended (the “Securities Act”). The issuance of the SSI Shares was completed in reliance upon Section 4(a)(2) of the Securities Act. The closing of the transactions contemplated by the Securities Purchase Agreement occurred on August 6, 2026.
Economic Conditions, Challenges and Risks
Our performance improved since the second half of 2025, driven by increased demand for our memory products and disciplined commercial execution. In our view, accelerated AI adoption has tightened industry supply relative to demand, contributing to broad-based price increases. We currently expect these dynamics to continue until additional industry fabrication capacity becomes available, potentially beginning in 2028; however, the timing, scale and effectiveness of any additional capacity, and the level of end-market demand when such capacity becomes available, may differ materially from our expectations. Increased industry fabrication capacity could improve component availability, place downward pressure on pricing, and shift product mix, any of which may moderate or adversely affect our volumes, pricing, margins and results of operations. The semiconductor industry is cyclical and subject to rapid changes in supply and demand. Demand for our products is significantly influenced by data-center and AI infrastructure investment, and changes in the pace of that investment, including as a result of financing conditions or as a result of regulatory, permitting or energy-related constraints on data-center construction, could affect the timing and amount of our product sales. Future demand for our products is inherently unpredictable. Our current results of operations may not be indicative of our future results.
In addition, the vast majority of our net product sales in recent periods have been generated from resales of products sourced from SK hynix pursuant to the Product Purchase and Supply Agreement with SK hynix, which was entered into on April 5, 2021 (the “SK hynix Supply Agreement”). The term of the supply provisions of this SK hynix Supply Agreement expired in April 2026. We continue to purchase products from SK hynix following expiration of the SK hynix Supply Agreement on a purchase order basis on similar terms to the prior SK hynix Supply Agreement, but SK hynix ultimately may not continue to supply us with products for resale on similar terms or at all. In such circumstances, our financial results, including our revenue, profits and margins in future periods may be adversely affected. In August 2026 and as noted above, we entered into the SSI Supply Agreement with Samsung Semiconductor providing us with the right to purchase up to $300 million of DRAM and NAND products per year for an aggregate of up to $1.5 billion over a five-year term. Should Samsung fail to comply with the terms of this agreement and the related arrangements, our financial results of operation would be adversely affected.
Our patent litigation with Samsung and Micron has been resolved pursuant to the Samsung Agreements and the Micron Agreements, and a significant portion of our near-term revenue and cash flow is now expected to be derived from license fees and net sales pursuant to these agreements. As a result, our results of operations and liquidity will depend on Samsung’s and Micron’s performance of their payment and supply obligations. Other proceedings, including our appeals to the CAFC, ex parte reexaminations at the USPTO, and our litigation with Google, remain pending, and we account for any potential recoveries from these matters as gain contingencies that are not recognized until realized. See “Legal Proceedings” in Part II, Item 1 of this report and See Note 6 to the condensed consolidated financial statements included in Part I, Item 1 of this report for more information.
34
We are also party to ongoing intellectual property litigation. While we have entered into the Samsung Settlement Agreement and Micron Settlement Agreement with Samsung and Micron, respectively, to resolve our pending patent litigations with Samsung and Micron, other matters remain subject to appeal and other proceedings, and any ultimate recovery from these matters may be less than any amounts awarded or may not be realized, including as a result of negotiated resolution, appeals, post-trial proceedings, patent office proceedings or other developments. We account for potential recoveries as gain contingencies and do not recognize them until realization is probable and reasonably estimable. The timing and amount of any recovery from these matters are inherently uncertain, prior settlements with Micron and Samsung may not be representative of any future litigation results, and any resolution of these ongoing matters could materially affect our results of operations or cash flows in the period in which it occurs. See “Legal Proceedings” in Part II, Item 1 of this report and See Note 6 to the condensed consolidated financial statements included in Part I, Item 1 of this report for more information.
Results of Operations
Net Sales and Gross Profit
Net sales and gross profit for the three and nine months ended September 26, 2026 and September 27, 2025 were as follows (dollars in thousands):
| | Three Months Ended | | | | Nine Months Ended | | | ||||||||
| | September 26, | | September 27, | | % | | September 26, | | September 27, | | % | ||||
| | 2026 | | 2025 | | Change | | 2026 | | 2025 | | Change | ||||
Net product sales | | $ | 60,194 | | $ | 42,234 | | 43% | | $ | 274,931 | | $ | 112,915 | | 143% |
License fee | | | 44,910 | | | — | | 100% | | | 44,910 | | | — | | 100% |
Net sales | | $ | 105,104 | | $ | 42,234 | | 149% | | $ | 319,841 | | $ | 112,915 | | 183% |
Cost of sales | | | 36,247 | | | 40,396 | | (10%) | | | 205,712 | | | 108,385 | | 90% |
Gross profit - product sales | | $ | 23,947 | | $ | 1,838 | | 1203% | | $ | 69,219 | | $ | 4,530 | | 1428% |
Gross margin percentage - product sales | | | 40% | | | 4% | | | | | 25% | | | 4% | | |
Gross profit | | $ | 68,857 | | $ | 1,838 | | 3646% | | $ | 114,129 | | $ | 4,530 | | 2419% |
Gross margin percentage | | | 66% | | | 4% | | | | | 36% | | | 4% | | |
Net Sales
Net sales include (i) resales of certain components, modules, and other products, including DIMMs and SSDs, and sales of our own products and (ii) license fee recognized for licensing of our patents pursuant to the Samsung License Agreement.
Net product sales increased by approximately $18.0 million during the third quarter of 2026 compared to the same period of 2025, primarily as a result of a $21.2 million increase in sales of low-profile memory subsystem products, and a $1.2 million increase in sales of our flash and SSDs products, partially offset by a $4.5 million decrease in the sale of registered Dual Inline Memory Module (“RDIMM”) and discrete memory component products.
Net product sales increased by approximately $162.0 million during the first nine months of 2026 compared to the same period of 2025, primarily as a result of a $117.8 million increase in the sale of RDIMM and discrete memory component products, a $42.8 million increase in sales of low-profile memory subsystem products, and a $1.4 million increase in sales of our flash and SSDs products.
35
These increases in net product sales are primarily due to strong customer demand in support of AI and data center applications.
Gross license fee revenue of $44.9 million for each of the third quarter and first nine months of 2026 represents amounts recognized under the Samsung License Agreement, which became effective July 1, 2026, consisting of $12.0 million of the upfront license fee recognized over 20 quarters and the $32.9 million quarterly license fee recognized for the third quarter of 2026, each inclusive of foreign withholding taxes paid by Samsung on our behalf. We had no license fee revenue in the corresponding periods of 2025. Beginning in the fourth quarter of 2026, we also expect to recognize license fee revenue under the Micron License Agreement pursuant to its terms with the amount in excess of the grant-date fair value over the $1.0 million of cash received under the Micron Purchase Agreement. The excess of the fair value of the shares over the purchase price, totaling $39.2 million, was accounted for as consideration payable to a customer and will be recognized as a reduction of license revenue over the five-year license term. Accordingly, we expect to recognize approximately $28.0 million of license revenue per quarter.
Gross Profit and Gross Margin
Product gross profit and gross margin percentage increased significantly during the third quarter and first nine months of 2026 compared to the same periods of 2025, primarily as a result of higher sales prices due to the current supply-demand environment discussed above and product sales mix.
Product gross profit increased by approximately $22.1 million during the third quarter of 2026 compared to the same period of 2025, primarily as a result of a $19.4 million increase in gross profit of RDIMM and discrete memory component products, and a $2.7 million increase in gross profit of low-profile memory subsystem products.
Product gross profit increased by approximately $64.7 million during the first nine months of 2026 compared to the same period of 2025, primarily as a result of a $55.3 million increase in gross profit of RDIMM and discrete memory component products, and a $9.4 million increase in gross profit of low-profile memory subsystem products.
Total gross margin percentage increased from 4% during the third quarter of 2025 to 66% in the same period of 2026, primarily due to license fee revenue under the Samsung License Agreement, which has no associated cost of sales, and higher product gross margin. Similarly, total gross margin percentage increased from 4% during the first nine months of 2025 to 36% in the same period of 2026 for these same reasons.
Operating Expenses
Operating expenses for the three and nine months ended September 26, 2026 and September 27, 2025, were as follows (dollars in thousands):
| | Three Months Ended | | | | Nine Months Ended | | | ||||||||
| | September 26, | | September 27, | | % | | September 26, | | September 27, | | % | ||||
| | 2026 | | 2025 | | Change | | 2026 | | 2025 | | Change | ||||
Research and development | | $ | 1,054 | | $ | 822 | | 28% | | $ | 3,205 | | $ | 2,548 | | 26% |
Percentage of net sales | | | 1% | | | 2% | | | | | 1% | | | 2% | | |
Intellectual property legal fees | | $ | 16,211 | | $ | 5,035 | | 222% | | $ | 41,938 | | $ | 15,542 | | 170% |
Percentage of net sales | | | 15% | | | 12% | | | | | 13% | | | 14% | | |
Selling, general and administrative | | $ | 11,021 | | $ | 3,131 | | 252% | | $ | 18,511 | | $ | 9,604 | | 93% |
Percentage of net sales | | | 10% | | | 7% | | | | | 6% | | | 9% | | |
36
Research and Development
Research and development expenses increased during the three and nine months ended September 26, 2026 compared to the same periods of 2025, primarily due to higher employee headcount and the associated increase in overhead costs. We expect research and development expenses to increase in future periods as we invest to support growth in our products business.
Intellectual Property Legal Fees
Intellectual property legal fees consist of fees incurred for patent enforcement and licensing, appeals, patent drafting and prosecution, and opposition to third-party post-grant patent proceedings. These fees may not be linear but may occur in lump sums depending on jury trial management, due dates of various filings and their associated fees, and the arrangements we may make with our legal advisors in connection with enforcement proceedings, which often include fee arrangements or contingent fee arrangements in which we pay these legal advisors on a scaled percentage of any negotiated fees, settlements or judgments awarded to us based on if, how and when the fees, settlements or judgments are obtained. See Note 6 to the condensed consolidated financial statements included in Part I, Item 1 of this report for further discussion. In addition, in connection with the settlement of our patent litigations with Samsung (see “Management’s Discussion and Analysis - Recent Developments” above) and Micron (see Note 10 to the condensed consolidated financial statements), we have incurred and expect to incur legal fees payable to outside counsel retained on a partial contingent fee basis, calculated as a percentage of amounts received under the Samsung Settlement Agreement, Samsung License Agreement, Micron Settlement Agreement, and Micron License Agreement. Such fees may be material to our results of operations and cash flows in the periods in which they become payable.
Intellectual property legal fees increased during the third quarter and first nine months of 2026 compared to the same periods of 2025 due primarily to higher legal expenses incurred to protect and enforce our patent portfolio, and $1.8 million of contingent fee in connection with our Samsung settlement. Contingent fees in connection with settlement agreements are incremental costs of obtaining a contract to be capitalized and amortized over the license term.
Selling, General and Administrative
Selling, general and administrative expenses increased during the third quarter and first nine months of 2026 compared to the same periods of 2025 primarily due to a $6.1 million increase in stock-based compensation expense, primarily related to the Chief Executive Officer Performance Equity Award granted in July 2026, higher corporate legal expenses, and sales commissions associated with higher sales. We expect our selling, general and administrative expenses will increase in future periods as we invest to support growth in our products business, expand our customer base, and when, if and as we recognize additional compensation expenses related to the Award and the retention bonuses for our Chief Executive Officer and Chief Financial Officer approved in November 2026 and described in Note 10 to the condensed and consolidated financial statements.
Other Income, Net
Other income, net for the three and nine months ended September 26, 2026 and September 27, 2025 was as follows (dollars in thousands):
| | Three Months Ended | | | | | Nine Months Ended | | | |||||||
| | September 26, | | September 27, | | % | | September 26, | | September 27, | | % | ||||
| | 2026 | | 2025 | | Change | | 2026 | | 2025 | | Change | ||||
Interest income, net | | $ | 864 | | $ | 106 | | | | $ | 945 | | $ | 459 | | |
Other income, net | | | 31 | | | 34 | | | | | 94 | | | 130 | | |
Total other income, net | | $ | 895 | | $ | 140 | | 539% | | $ | 1,039 | | $ | 589 | | 76% |
37
Interest income, net increased during the third quarter and first nine months of 2026 compared to the same periods of 2025, primarily as a result of interest earned on higher cash balances. Other income, net included a deposit returned for our former manufacturing facility located in the People’s Republic of China during the first nine months of 2025.
Provision for Income Taxes
We recorded an income tax benefit of $44.0 million for the third quarter and first nine months of 2026, compared to no provision for income taxes in the corresponding periods of 2025. The provision primarily relates to Korean withholding taxes on license fee payments under the Samsung License Agreement, which Samsung is required to gross up, and U.S. federal and state income taxes on taxable income from the license and settlement arrangements, after utilization of available net operating loss carryforwards. During the third quarter of 2026, we released $56.5 million of valuation allowance because we concluded it is more likely than not that the related deferred tax assets will be realized from projected taxable income, and we continue to maintain a $23.0 million valuation allowance against deferred tax assets we do not expect to realize. We will reassess our valuation allowance and estimated annual effective tax rate each quarter as projections change.
Liquidity and Capital Resources
Our primary sources of cash were historically proceeds from issuances of equity and receipts from net product sales. In addition, in August 2026 we received the upfront license fee under the Samsung License Agreement, and we may receive quarterly license fees pursuant to the terms of the Samsung License Agreement through the second calendar quarter of 2031 and under the Micron License Agreement from the fourth calendar quarter of 2026 through the third calendar quarter of 2031. These receipts will be partially offset by contingent fees payable to outside counsel as amounts are received and the potential effects of changes in variable consideration recognition. We previously received proceeds from the SK hynix Supply Agreement, which we used to support our operations. Historically, we have also funded our operations with our revolving line of credit under a bank credit facility with SVB and funds raised through the March 2025 Purchase Agreement, our October 2025 Offering, June 2025 Offering and warrant exercises.
The following tables present selected financial information as of September 26, 2026 and December 27, 2025 and for the first nine months of 2026 and 2025 (in thousands):
| | September 26, | | December 27, | ||
| | 2026 | | 2025 | ||
Cash, cash equivalents and restricted cash | | $ | 327,685 | | $ | 42,082 |
Working capital | | | 209,448 | | | (6,432) |
| | Nine Months Ended | ||||
| | September 26, | | September 27, | ||
| | 2026 | | 2025 | ||
Net cash provided by (used in) operating activities | | $ | 244,991 | | $ | (27,995) |
Net cash used in investing activities | | | (185) | | | (25) |
Net cash provided by financing activities | | | 40,797 | | | 14,257 |
During the nine months ended September 26, 2026, net cash provided by operating activities was primarily a result of net income of $95.5 million, partially offset by non-cash adjustments to net income of ($79.9) million, primarily related to the deferred income tax benefit, and net cash inflows from changes in operating assets and liabilities of $229.4 million driven predominantly by an increase of deferred revenue related to unrecognized upfront license fee and advance payments from customers, an increase in accounts payable, and an increase in accrued payroll and related liabilities, partially offset by an increase in accounts receivable, an increase in inventories, and a decrease in other liabilities. Net cash provided by financing activities during the nine months ended September 26, 2026 primarily consisted of $42.0 million in net proceeds from exercise of stock options and warrants, and $1.0 million in net proceeds from the issuance of common stock under Samsung Securities Purchase Agreement (as defined below), partially offset by $1.8 million in net
38
repayments under the 2023 SVB Credit Agreement (as defined below), and $0.4 million in payments of notes payable to finance insurance policies.
During the nine months ended September 27, 2025, net cash used in operating activities was primarily a result of net loss of $22.6 million, non-cash adjustments to net loss of $2.7 million, and net cash outflows from changes in operating assets and liabilities of $8.2 million driven predominantly by a decrease in accounts payable, an increase in inventories due to orders not shipped in September 2025, an increase in prepaid expenses and other assets, partially offset by an increase in deferred revenue related to advance payments received on orders shipped in October 2025. Net cash provided by financing activities during the nine months ended September 27, 2025 primarily consisted of $1.1 million in net proceeds from the issuance of common stock under the March 2025 Purchase Agreement (as defined below) and $11.6 million in net proceeds from issuance of common stock under the June 2025 Purchase Agreement (as defined below), $2.2 million in net borrowings under the 2023 SVB Credit Agreement (as defined below), partially offset by $0.5 million in payments of notes payable to finance insurance policies.
Capital Resources
March 2025 Lincoln Park Purchase Agreement
On March 13, 2025, we entered into a purchase agreement (the “March 2025 Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which we have the right to sell to Lincoln Park up to an aggregate of $75 million in shares of our common stock over the 36-month term of the March 2025 Purchase Agreement subject to the conditions and limitations set forth in the March 2025 Purchase Agreement. As of September 26, 2026, $73.7 million remains available under the March 2025 Purchase Agreement with Lincoln Park. Sales under the March 2025 Purchase Agreement are subject to daily volume-based limits and a contractual floor price, and our ability to access the remaining capacity at any point in time depends on prevailing market prices and trading volumes.
October 2025 Offering
On October 6, 2025, we entered into a Securities Purchase Agreement (the “October 2025 Purchase Agreement”) with certain investors (collectively, the “October 2025 Purchasers”), pursuant to which we issued and sold to the October 2025 Purchasers in a registered offering (the “October 2025 Offering”) an aggregate of (i) 14,285,716 shares of our common stock and (ii) Common Stock Purchase Warrants (the “October 2025 Warrants”) to purchase up to an aggregate of 28,571,432 shares of our common stock (the “October 2025 Warrant Shares”) at a combined purchase price of $0.70 per share and accompanying October 2025 Warrant. The October 2025 Offering closed on October 7, 2025. The net proceeds to us from the October 2025 Offering were approximately $9.3 million, after deducting placement agent fees and offering costs paid by us.
The October 2025 Purchase Agreement also provided that we could not, subject to the exceptions described in the October 2025 Purchase Agreement (including an exception permitting us to utilize the March 2025 Purchase Agreement following the expiration of the 90-day period following the closing of the October 2025 Offering), effect or enter into any Variable Rate Transactions (as defined in the October 2025 Purchase Agreement) until the six-month anniversary of the closing date of the October 2025 Offering.
June 2025 Offering
On June 24, 2025, we entered into a Securities Purchase Agreement (the “June 2025 Purchase Agreement”) with certain investors, including Chun K. Hong, Chairperson of our Board of Directors (the “Board” or “Board of Directors”), President and Chief Executive Officer (collectively, the “June 2025 Purchasers”), pursuant to which we issued and sold to the June 2025 Purchasers in a registered offering (the “June 2025 Offering”) an aggregate of (i) 17,142,860 shares of our common stock and (ii) Common Stock Purchase Warrants (the “June 2025 Warrants”) to purchase up to an aggregate of 34,285,720 shares of our common stock (the “June 2025 Warrant Shares”) at a combined purchase price of $0.70 per share and accompanying June 2025 Warrant. Mr. Hong purchased $3.0 million of shares and accompanying June 2025 Warrants in the June 2025
39
Offering. The June 2025 Offering closed on June 25, 2025. The net proceeds to us from the June 2025 Offering were approximately $11.6 million, after deducting placement agent fees and offering costs paid by us.
The June 2025 Purchase Agreement also provided that we could not, subject to the exceptions described in the June 2025 Purchase Agreement (including an exception permitting us to utilize the March 2025 Purchase Agreement following the expiration of the 90-day period following the closing of the June 2025 Offering), effect or enter into any Variable Rate Transactions (as defined in the June 2025 Purchase Agreement) until the six-month anniversary of the closing date of the June 2025 Offering.
Securities Purchase Agreements
On August 4, 2026, in connection with and as a condition to the parties’ entry into the SSI Supply Agreement and effective as of July 31, 2026, we entered into a Securities Purchase Agreement and a Lock-Up and Release Agreement with Samsung Semiconductor. Pursuant to the Securities Purchase Agreement, Samsung Semiconductor purchased the SSI Shares for an aggregate cash purchase price of $1 million. Pursuant to the Lock-Up and Release Agreement, twenty percent of the SSI Shares will be released from the disposition and transfer restrictions set forth therein on each of the first, second, third and fourth anniversaries of the issuance of the SSI Shares, with the remaining SSI Shares released on the fifth anniversary. The issuance of the SSI Shares to Samsung Semiconductor was not registered under the Securities Act. The issuance of the SSI Shares was completed in reliance upon Section 4(a)(2) of the Securities Act. The closing of the transactions contemplated by the Securities Purchase Agreement occurred on August 6, 2026.
On October 5, 2026, we entered into the Micron Purchase Agreement and the Micron Lock-Up and Release Agreement with Micron Technology, Inc. Pursuant to the Micron Purchase Agreement, Micron Technology purchased the Micron Shares for an aggregate cash purchase price of $1 million. Pursuant to the Micron Lock-Up and Release Agreement, twenty percent of the Micron Shares will be released from the disposition and transfer restrictions set forth therein on each of the first, second, third and fourth anniversaries of the issuance of the Micron Shares, with the remaining Micron Shares released on the fifth anniversary. The issuance of the Micron Shares to Micron Technology, Inc. was not registered under the Securities Act. The issuance of the Micron Shares was completed in reliance upon Section 4(a)(2) of the Securities Act. The closing of the transactions contemplated by the Micron Purchase Agreement occurred on October 7, 2026.
2023 SVB Credit Agreement
On November 7, 2023, we entered into a loan and security agreement (as amended to date, the “2023 SVB Credit Agreement”) with SVB, which provides for a revolving line of credit up to $10.0 million. The borrowing base is limited to 85% of eligible accounts receivable, subject to certain adjustments. Borrowings accrue interest on advances at a per annum rate equal to the greater of 8.50% and the Wall Street Journal prime rate. The maturity date was originally November 7, 2025. On November 7, 2025, we entered into a first amendment to the loan and security agreement (the “2023 SVB Credit Agreement Amendment”) to, among other things, extend the maturity date from November 7, 2025 to November 7, 2027.
As of September 26, 2026, the outstanding borrowings under the 2023 SVB Credit Agreement were $0 with $4.2 million available under the revolving line of credit. During the nine months ended September 26, 2026, we had net repayments of $1.8 million under the 2023 SVB Credit Agreement; because borrowing capacity is driven by eligible receivables and reserve adjustments, availability may fluctuate with collections and sales mix, and letters of credit issued under the facility and with other banks are secured by cash and reduce unrestricted liquidity.
Warrant Exercises
During the nine months ended September 26, 2026, we received $41.7 million in proceeds from the cash exercise of issued and outstanding warrants to purchase 59,096,756 shares of common stock. Future warrant
40
exercises will likely depend on market conditions, the strategies of the individual warrant holders, and are ultimately at the discretion of the individual warrant holders. As such, future warrant exercises (if any) may be unpredictable and may not be representative of recent exercise activity.
Sufficiency of Cash Balances and Potential Sources of Additional Capital
We believe our existing balance of cash and cash equivalents (including restricted cash balances), which totaled $327.7 million as of September 26, 2026, along with cash receipts from revenues, payments pursuant to the Samsung License Agreement (with the upfront payment received in August 2026) and the Micron License Agreement, potential borrowing availability, if any, under the 2023 SVB Credit Agreement, funds available through the March 2025 Purchase Agreement, proceeds received from potential warrant exercises, and other future debt and equity offerings and taking into account cash expected to be used in our operations, will be sufficient to meet our anticipated cash needs for at least the next 12 months. This belief reflects our current assessment of known trends and uncertainties that could affect near-term liquidity, including the timing of cash effects from customer advance payments, fluctuations in borrowing-base availability and letters-of-credit usage and market conditions that affect our ability to utilize the March 2025 Purchase Agreement. However, this estimate may ultimately be incorrect and we may use our cash resources faster than we expect as a result of many factors, including costs to defend our intellectual property portfolio, the results of ongoing litigation and legal proceedings, demand and acceptance of our products, whether our current customers continue purchasing our products, costs of developing and improving our products, our results of operations, including our level of net product sales that we receive which can vary based on a number of factors, including the amount and timing of vendor payments, the timing of customer orders, the effects of changes in international trade policy, non-recurring items and changing projected inventory needs and estimates. Beyond the next 12 months, we expect our principal sources of liquidity to include cash receipts from product sales and the quarterly license fees payable under the Samsung License Agreement and the Micron License Agreement through 2031. We expect our material cash requirements over the next 12 months and in the longer term to include cash retention bonus payments for our Chief Executive Officer and Chief Financial Officer, contingent fees payable to outside counsel in connection with payments received pursuant to our Samsung and Micron agreements, U.S. federal and state income taxes (to the extent not offset by available net operating loss carryforwards and foreign tax credits), purchases of DRAM and NAND products under the SSI Supply Agreement, which provides us the right, but not the obligation, to purchase up to $300 million of products per year, other purchases of inventory, lease obligations, strategic transactions, and the pursuit of such opportunities, and costs and expenses related to the continued enforcement and protection of our intellectual property portfolio.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditure or capital resources that is material to investors.
Recent Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which updates expense disclosure requirements on an annual and interim basis. This ASU is effective for the annual periods beginning after December 15, 2026, and the interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU.
In May 2025, the Financial Accounting Standards Board issued ASU 2025-04, Compensation – Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer, which clarifies accounting for shares, warrants, and other share-based awards an entity grants to its customers. This ASU is effective for the annual periods beginning
41
after December 15, 2026, including interim periods within those annual periods. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU.
Critical Accounting Policies and Use of Estimates
The preparation of our condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net sales and expenses during the reporting period. By their nature, these estimates and assumptions are subject to an inherent degree of uncertainty. We base our estimates and assumptions on our historical experience, knowledge of current conditions and our beliefs of what could occur in the future considering available information. We review our estimates and assumptions on an ongoing basis. Actual results may differ from our estimates, which may result in material adverse effects on our consolidated operating results and financial position.
Our critical accounting policies and estimates are discussed in Note 1 to the condensed consolidated financial statements in this report and in the notes to consolidated financial statements in Part II, Item 8 of our Annual Report and in the MD&A in our Annual Report. Other than the addition of revenue recognition for patent license arrangements, including the identification of performance obligations, the timing of their satisfaction and estimates of variable consideration, including the constraint on variable consideration, and the grant-date fair value of common stock issued to a supplier, including the discount for lack of marketability for post-vesting transfer restrictions and accounting for income taxes as each described below, there have been no significant changes to our critical accounting policies since our Annual Report.
Revenue Recognition
Intellectual Property License and Royalty Revenue
During the third quarter of 2026, we entered into a five-year patent license agreement under which we granted Samsung Electronics a license to our patent portfolio. Under the Samsung License Agreement, we may receive total license fees of up to $750.0 million, consisting of a $200.0 million upfront license fee and quarterly license fees of up to $27.5 million per quarter for 20 quarters, subject to variable consideration described below. Including foreign withholding taxes paid by Samsung on our behalf, the total potential consideration is up to approximately $898.2 million. During the third quarter of 2026, we received $227.5 million ($272.5 million inclusive of foreign withholding taxes paid by Samsung on our behalf), consisting of the upfront license fee and the first quarterly license fee. License fee revenue is recognized inclusive of foreign withholding taxes paid by Samsung on our behalf, as described below.
Our intellectual property license and royalty revenue is comprised of licenses which provide Samsung the right to access our portfolio of patents, including patents added to the portfolio during the license term, in exchange for license fees and sales-based royalties. License fee revenue is recognized on a straight-line basis over the license term. Royalty revenue is recognized in the fiscal quarter to which the royalty relates. License fees and royalties are recognized gross of foreign withholding taxes paid by Samsung on our behalf, which are recorded as an income tax asset until utilized.
Performance Obligations
Our intellectual property license and royalty revenue includes a single performance obligation to provide Samsung with the right to access our patent portfolio, including patents added to the portfolio during the license term, which is satisfied over time. We use a time-elapsed measure of progress because the licensing rights are made available to the customer evenly throughout the license term.
42
Royalties are variable consideration based on Samsung’s reported revenue and are recognized in accordance with the sales-based royalty guidance under ASC Topic 606, Revenue from Contracts with Customers, in the calendar quarter to which the royalty relates. We have elected the optional exemption not to include sales-based royalties in the remaining performance obligation disclosed under Contract Assets and Liabilities below; these royalties will be determined quarterly over the remaining license term through July 2031. The remaining performance obligation also excludes variable consideration that is constrained, as described under Variable Consideration below.
Variable Consideration
Our licensing agreement includes variable consideration that is contingent upon events occurring in the later periods of the contract. We include variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the related matters are resolved. We reassess the estimate of variable consideration at each reporting date. Changes to our estimate of variable consideration are accounted for as changes in the transaction price. Based on our current estimates, no variable consideration was excluded from the transaction price.
Contract Assets and Liabilities
We continually evaluate whether the revenue generating activities and advanced payment arrangements with customers result in the recognition of contract assets or liabilities. Generally, we do not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities (deferred revenues) are comprised of payments received from our customers in advance of transferring products to customers and upfront license fees received in advance of satisfying our license performance obligation over the license term.
As of September 26, 2026 and December 27, 2025, deferred revenue was $258.0 million and $30.6 million, respectively. Deferred revenue at September 26, 2026 included $227.5 million related to the unrecognized upfront license fee, of which $47.9 million is expected to be recognized within the next 12 months and the remainder through July 2031. The remaining $30.5 million related to advance payments received during the third quarter of 2026 on product orders shipped subsequent to the end of the quarter. Deferred revenue at December 27, 2025 was related to advance payments received during the quarter on product orders shipped subsequent to the end of the quarter.
During the three and nine months ended September 26, 2026, we recognized $3.0 million and $30.6 million, respectively, of revenue included in deferred revenue at the beginning of each period, all related to product orders.
We capitalize incremental costs of obtaining contracts with customers when such costs are expected to be recovered. These costs include contingent legal fees that would not have been incurred if the related contracts had not been obtained. Legal fees and other costs that do not qualify for capitalization are expensed as incurred.
Capitalized contract acquisition costs are amortized on a systematic basis consistent with the transfer of the goods or services to which the costs relate and are evaluated for impairment in accordance with ASC 340-40.
In connection with our license agreement with Samsung, we capitalized contingent legal fees that represent incremental costs of obtaining the agreement and are expected to be recovered through the consideration received under the agreement. These costs are being amortized on a straight-line basis over the 20-quarter license term, consistent with the recognition of the related license revenue.
As of September 26, 2026, capitalized contract acquisition costs totaled approximately $32.9 million, consisting of $7.2 million classified as current assets and $25.6 million classified as noncurrent assets in the accompanying condensed consolidated balance sheets. Amortization expense related to these costs was approximately $1.8 million for the three and nine months ended September 26, 2026.
43
Prepaid Vendor Nonrefundable Deposit
Equity instruments issued to suppliers for goods or services are accounted for under ASC 718, Compensation—Stock Compensation. When the supplier is also a customer or customer affiliate, we apply the consideration payable to a customer guidance in ASC 606. The grant-date fair value of common stock subject to post-vesting transfer restrictions reflects a discount for lack of marketability.
Advance payments for contractual rights to access supplier products are recorded as prepaid vendor nonrefundable deposit assets and recognized in cost of sales on a straight-line basis over the contract term. Amounts expected to be recognized within 12 months are classified as prepaid expenses and other current assets, with the remainder classified as other assets. Recoverability is assessed at each reporting date, and any unamortized balance is recognized in cost of sales upon early termination of the supply arrangement.
Income Taxes
We recorded income tax benefit of $44.0 million and $44.0 million for the three and nine months ended September 26, 2026, respectively. We recorded no income tax provision for the three and nine months ended September 27, 2025.
Our effective tax rate was (85.4)% and (85.4)% for the three and nine months ended September 26, 2026, respectively, and 0% for the three and nine months ended September 27, 2025. The effective tax rate for the 2026 periods differs from the U.S. statutory rate of 21% primarily due to the discrete benefit from the release of valuation allowance described below.
During the third quarter of 2026, we released $56.5 million of its valuation allowance on federal and state deferred tax assets. Of this amount, $48.6 million was recognized as a discrete benefit resulting from a change in judgment about the realizability of beginning-of-year deferred tax assets. The remaining $7.9 million is reflected in the estimated annual effective tax rate. Management based this conclusion on all available positive and negative evidence, including cumulative income in recent years and projected future taxable income, and concluded it is more likely than not that these deferred tax assets will be realized.
As of September 26, 2026, we maintained a valuation allowance of $23.0 million, primarily against federal net operating loss carryforwards expected to be utilized against projected 2026 taxable income and foreign tax credits that are not expected to be utilized due to limitation. The remainder relates to certain state and China deferred tax assets. We will continue to evaluate the realizability of its deferred tax assets in future periods.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Not Applicable.
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, and we maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.
44
In designing our disclosure controls and procedures and internal control over financial reporting, our management recognizes that any control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. Further, the design of our controls and procedures must reflect the fact that there are resource constraints, and management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Because of the inherent limitations, our disclosure and internal controls may not prevent or detect all instances of fraud, misstatements or other control issues, and our evaluations of disclosure and internal controls cannot provide assurance that all such control issues have been detected. In addition, projections of any evaluation of the effectiveness of disclosure or internal controls to future periods are subject to risks, including, among others, that controls may become inadequate because of changes in conditions or that compliance with policies or procedures may deteriorate.
Our management conducted an evaluation, with the participation of our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) as of the end of the period covered by this report. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework. Based on this evaluation, our management concluded there was a material weakness in our internal controls due to the historical lack of independent Board member and audit committee oversight of our financial reporting process until the recent Board appointments and audit committee’s reformation in June 2025. While we now have a standing audit committee comprised of an independent Board member, this oversight will need to operate effectively for a sufficient period of time before management may consider our previously identified material weakness to be remediated. As a result of these circumstances, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were not effective as of September 26, 2026.
While we are not required to provide an auditor’s attestation report on internal control over financial reporting in this Form 10-Q, our independent registered public accounting firm expects to conduct an integrated audit of our financial statements and internal control over financial reporting in preparation for our Form 10-K for the year ending January 2, 2027 due to the fact that we expect to become a large accelerated filer and no longer qualify as a smaller reporting company beginning with our Annual Report on Form 10-K for fiscal 2026. An integrated audit involves both an opinion on the financial statements and an opinion on the effectiveness of internal control over financial reporting, in accordance with the Public Company Accounting Oversight Board Auditing Standard No. 2201.
Notwithstanding the material weakness in our internal control over financial reporting, we have concluded that the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.
Changes in Internal Control over Financial Reporting and Remediation Initiatives
In June 2025, we formed an audit committee of our Board (the “Audit Committee”) and appointed two additional independent members of our Board of Directors, one of whom who was appointed to serve on the Audit Committee. This Audit Committee now assists in evaluating our system of internal controls and provides oversight of our financial reporting process. Despite the reformation of our Audit Committee and these recent appointments, the material weakness discussed above cannot be considered remediated until these controls operate for a sufficient period and management has concluded, through testing, that our internal controls are operating effectively.
There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 26, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
45
PART II. — OTHER INFORMATION
Item 1. | Legal Proceedings |
The information under “Commitments and Contingencies” in Note 6 to the condensed consolidated financial statements included in Part I, Item 1 of this report is incorporated herein by reference.
Item 1A. | Risk Factors |
There have been no material changes to the risk factors set forth in “Risk Factors” in Part I, Item 1A of our Annual Report filed with the SEC on March 19, 2026 and in Part II, Item 1A of our Quarterly Report filed with the SEC on August 11, 2026.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
None.
Item 3. | Defaults Upon Senior Securities |
None.
Item 4. | Mine Safety Disclosures |
Not applicable.
46
Item 5. | Other Information |
Insider Trading Arrangements
During the fiscal quarter ended September 26, 2026, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act) adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as those terms are defined in Item 408 of Regulation S-K), except as follows:
On
Transaction and Retention Bonus Letters
On November 6, 2026, the independent members of our Board of Directors, advised by the Board's independent compensation consultant, approved one-time cash bonuses for Chun K. Hong, our President and Chief Executive Officer, and Gail Sasaki, our Executive Vice President and Chief Financial Officer, in recognition of their contributions to our multiyear intellectual property monetization strategy, including the negotiation and execution of the Samsung License Agreement and the Micron License Agreement, and to promote their continued retention. On November 6, 2026, we entered into bonus letters with Mr. Hong and Ms. Sasaki reflecting these awards.
Mr. Hong is eligible to receive a cash retention bonus of $25.0 million, payable $10.0 million on November 9, 2026 and $3.75 million on each of February 15, May 15, August 15 and November 15, 2027, subject to his continued employment through each payment date. Unpaid installments will be paid in a lump sum upon a termination without cause, a resignation for good reason (subject to a release of claims) or a change in control. If Mr. Hong resigns without good reason or is terminated for cause within three years after November 6, 2026, he must repay a pro rata portion of the amounts paid (or, upon a termination for cause, all of those amounts).
Ms. Sasaki will receive a lump-sum cash retention bonus of $4.0 million. If she resigns without good reason or is terminated for cause within two years after November 6, 2026, she must repay a pro rata portion of the bonus (or, upon a termination for cause, the full bonus). This repayment obligation ceases upon a change in control.
The foregoing description of the retention bonus letters is qualified in its entirety by reference to the retention bonus letters for Mr. Hong and Ms. Sasaki, which are filed as Exhibits 10.9 and 10.10, respectively, to this Quarterly Report on Form 10-Q.
47
Item 6. | Exhibits |
48
| | | | Filed | | Incorporated by Reference | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Exhibit No. | | Exhibit Description | | Herewith | | Form | | File No. | | Filing Date |
101.CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document | | X | | | | | | |
101.LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document | | X | | | | | | |
101.PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document | | X | | | | | | |
101.DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document | | X | | | | | | |
104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | | | | | | | | |
+ | Furnished herewith. |
# | Management contract or compensatory plan or arrangement. |
* | Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential. |
˄ | Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplementally a copy of any omitted exhibit or schedule upon request by the SEC; provided, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any exhibits or schedules so furnished. |
49
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:November 10, 2026 | Netlist, Inc. | |
| | |
| | |
| By: | /s/ Chun K. Hong |
| | Chun K. Hong |
| | President, Chief Executive Officer and Director |
| | (Principal Executive Officer) |
| | |
| By: | /s/ Gail Sasaki |
| | Gail Sasaki |
| | Executive Vice President and Chief Financial Officer |
| | (Principal Financial and Accounting Officer) |
| | |
50
Exhibit 10.3
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
PATENT CROSS LICENSE AGREEMENT
This Patent Cross License Agreement (this “Agreement”) is made and entered into as of July 31, 2026 (“Effective Date”) by and between Netlist, Inc., a Delaware corporation having its principal place of business at 111 Academy Way, Suite 100, Irvine, CA 92617 (“Netlist”), and Samsung Electronics Co., Ltd., acting through Device Solutions, a company existing under the laws of the Republic of Korea, with its place of business at 1-1, Samsungjeonja-ro, Hwaseong-si, Gyeonggi-do, 18448 Korea (“Samsung”).
WHEREAS, the Parties desire to grant to each other a license under their respective Licensed Patents on the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the mutual covenants, agreements, licenses, and other rights and obligations set forth herein, the Parties hereby agree as follows:
1.Definitions. Capitalized terms, when used in this Agreement, have the meaning ascribed to them in this Section 1 or elsewhere in this Agreement.
1.1“Affiliate” means, with respect to a Person, any other Person that now or at any time thereafter during the Capture Period directly or indirectly Controls, is Controlled by, or is under common Control with that Person, where “Control” means ownership of more than fifty percent (50%) of the capital or voting stock, or equivalent ownership interests, of such Person. A Person is an “Affiliate” only as long as such Control exists.
1.2“Capture Period” means the period from the Effective Date until the fifth (P) anniversary of the Effective Date.
1.3“Captured Patents” means (a) with respect to Netlist, all Patents owned or otherwise licensable or enforceable by Netlist or its Affiliates on the Effective Date or at any time thereafter during the Capture Period, and (b) with respect to Samsung, [***].
1.4[***]
1.5[***]
1.6“License Fees” means the Upfront Payment and Quarterly Payments.
1.7“License Term” means the period beginning on the Effective Date and ending on the fifth (5th) anniversary of the Effective Date.
1.8“Licensed Patents” means the Parties’ respective Captured Patents, [***].
1.9“Licensed Products” [***]
1.10[***]
1.11[***]
1.12[***]
1.13“Party” means each of Netlist and Samsung, individually, and “Parties” means Netlist and Samsung, collectively.
1.14“Patents” means, throughout the world, all classes and types of utility patents, inventor’s certificates, utility models, and similar rights, and all applications, provisional applications, and registrations for any of the foregoing.
1.15“Person” means any person or entity, whether an individual, corporation, partnership, limited partnership, limited liability company, trust, foundation, unincorporated organization, business association, firm, joint venture, or other legal entity.
1.16“Product” means any product, apparatus, equipment, machine, manufacture, software, hardware, composition of matter, or material, including any component, integrated circuits, sub-assemblies, devices, part, system, or combination of the foregoing.
1.17[***]
1.18“Sell” means sell, offer for sale, distribute, provide, or otherwise dispose of, directly or indirectly. “Sale,” “Sold,” and other forms have the corresponding meaning.
1.19[***]
1.20[***]
1.21[***]
1.22[***]
1.23[***]
1.24[***]
1.25“Third Party” means any Person that is neither a Party nor an Affiliate of a Party.
2.License Grant
2.1Grant of License. Subject to the terms and conditions of this Agreement, each Party (in such capacity, a “Licensor”), on behalf of itself and its Affiliates, hereby grants to the other Party (in such capacity, a “Licensee”) and its Affiliates a worldwide, non-exclusive, non-transferable (except as permitted under Section 8.1), non-sublicensable, royalty-bearing (in the case of Samsung as Licensee) or royalty-free (in the case of Netlist as Licensee), license under the
2
Licensor’s Captured Patents to make, have made, use, Sell, and import Licensed Products during the License Term.
2.2[***]
2.3[***]
2.4[***]
2.5Irrevocability. Subject to, in the case of Samsung as Licensee, Samsung’s fulfillment of its payment obligations under Section 3 and the Party’s termination rights under Section 7.2, the licenses and any other rights and benefits granted to a Party and its Affiliates under this Agreement will not be revoked, rescinded, cancelled, terminated, or otherwise invalidated, in whole or in part, for any reason whatsoever, other than as a result of the expiration of the License Term [***].
2.6No Patent Laundering. Each Party acknowledges and agrees that the licenses granted under this Agreement are intended solely to cover the bona fide Products and activities of Licensee and its Affiliates and are not intended to extend, directly or indirectly, to any Products, services, or activities of a ‘Third Party in a manner that would constitute patent laundering or otherwise circumvent the intended scope and limitations of the licenses granted herein.
2.7Limitations on Rights. If a Licensor and its Affiliates lack the right to grant a license to the full extent set forth in this Agreement under any particular Licensed Patent, then the license granted herein with respect to such Licensed Patent is of the fullest extent that the Licensor or its Affiliates has the right to grant within the scope set forth in this Agreement.
2.8No Other Rights. Except as expressly set forth in this Agreement, no license, immunity, interest, authorization, or other right is granted or otherwise conveyed under this Agreement, whether directly, by implication, by reason of estoppel, or otherwise.
3.License Fees.
3.1Upfront Payment. Samsung will pay to Netlist [***] (the “Upfront Payment”).
3.2Quarterly Payments. For each calendar quarter from the Effective Date, including the partial calendar quarter ending September 2026, through (and including) the second calendar quarter of 2031 (for a total of 20 calendar quarters), Samsung will pay Netlist a recurring license fee [***] (each, a “Quarterly Payment”); [***].
3.3Payment Terms. All payments due hereunder will be made in U.S. Dollars by wire transfer to the following account:
[***]
Netlist shall issue an invoice to Samsung for each of the License Fees, and for the first invoice with respect to the Upfront Payment, Netlist shall provide (a) Certificate of incorporation, and (b)
3
a completed Application for Entitlement to Reduced Tax Rate on Domestic Source Income (for Foreign Corporation) (Form No. 72-2), and (c) additional documents, information, and/or other form of reasonable cooperation that may be necessary to complete the payment. Notwithstanding anything to the contrary herein, if the invoice is delayed, or the invoice is not accompanied by the foregoing documents, the due date of corresponding License Fees may be correspondingly delayed. [***]
3.4[***]
3.5[***]
3.6[***]
3.7[***]
3.7.1[***]
3.7.2[***]
4.No Challenge. Each Party agrees that, while the other Party’s Licensed Patents are licensed to such Party pursuant to this Agreement, it will not challenge, or assist in or support any Third Party’s challenge of, the validity, enforceability, or patentability of any of the other Party’s Licensed Patents in any forum or in any type of proceeding, provided that the foregoing will not restrict such Party (a) from complying with any subpoena, court order, or legal process, or (b) from challenging the validity, enforceability, or patentability of any of the other Party’s Licensed Patents in response to an assertion in a legal proceeding of such Licensed Patent against such Party or its Affiliates or their respective Products.
5.Representations, Warranties, and Disclaimers
5.1General Representations. Each Party represents and warrants that (a) it has all requisite corporate power and authority to execute and deliver this Agreement and to carry out the provisions of this Agreement on its own behalf and on behalf of its Affiliates, (b) the execution, delivery, and performance by such Party of this Agreement have been approved by all requisite action on the part of such Party, and no other proceedings, approvals, consents, authorizations, or other acts on the part of such Party are necessary to authorize this Agreement, (c) such Party’s execution, delivery, and performance of this Agreement do not and will not conflict with, violate, or result in any breach of any relevant law or provision of any license, agreement, contract, understanding, arrangement, commitment, or undertaking of any nature (whether written or oral) to which such Party is a party or by which such Party is otherwise bound.
5.2Additional Representation. Each Party further represents and warrants that it has the full right, power, and authority to grant the licenses and other rights granted by it under this Agreement, and such licenses and other rights are valid, effective, and enforceable in accordance with their terms.
5.3[***]
4
5.4Disclaimer. Except as expressly set forth in this Agreement (a) neither Party makes any representations or warranties with respect or relating to its Patents or otherwise with respect or relating to this Agreement; and (b) each Party hereby disclaims all other representations and warranties, whether express, implied, or statutory, including, without limitation, any warranty of title, non-infringement, merchantability, and fitness for a particular purpose, and any and all warranties that may arise from course of dealing, course of performance, or usage of trade. Nothing contained in this Agreement will be construed as a warranty or representation by either Party as to the validity, enforceability, quality, scope, or sufficiency of any Patents. Neither Party will have any obligation hereunder, and each Party retains sole and absolute discretion, to prosecute, maintain, defend, enforce, or otherwise assert any of its Patents, subject only to the licenses granted herein.
6.Limitation of Liability. Neither Party will be liable for any indirect, incidental, consequential, special, or punitive damages, or any lost profits, loss of business, or loss of opportunity, arising out of or relating to this Agreement, irrespective of whether such Party has been advised of the possibility of any such damages.
7.Term and Termination.
7.1Term. This Agreement is effective on the Effective Date and continues in effect until the expiration of the License Term [***], subject to earlier termination under Section 7.2. This Agreement will not automatically renew.
7.2Termination. Netlist may terminate Samsung’s licenses granted pursuant to this Agreement upon a failure by Samsung to make any payments due hereunder, which failure remains uncured thirty (30) days after the notice of such failure; provided that, subject to the foregoing, the licenses and other rights granted under this Agreement will not otherwise be revoked, rescinded, cancelled, terminated, or otherwise invalidated, in whole or in part, for any reason whatsoever, other than as a result of expiration of the License Term [***].
7.3Survival. All rights and obligations hereunder which by their nature are intended to survive the expiration or termination of this Agreement, including Sections 5.3, 5.4, 6, and 8, and, as specified in Section 7.1, will survive such expiration or termination.
8.Miscellaneous.
8.1[***]
8.2Relationship of the Parties. In the exercise of their respective rights and the performance of their respective obligations hereunder, the Parties are and will remain independent contractors. Nothing in this Agreement will be construed to constitute the Parties as partners, or principal and agent, for any purpose whatsoever. Neither Party will bind, or attempt to bind, the other Party to any contract or other obligation, and neither Party will represent to any Third Party that it is authorized to act on behalf of the other Party.
8.3Governing Law. This Agreement will be governed by and construed in accordance with the laws of [***].
5
8.4Venue. [***]
8.5No Waiver. The waiver by either Party of a breach or default of any provision of this Agreement by the other Party will not be construed as a waiver of any succeeding breach of the same or any other provision, nor will any delay or omission on the part of either Party to exercise or avail itself of any right, remedy, power, or privilege that it has or may have hereunder operate as a waiver of any right, remedy, power, or privilege by such Party and will not in any way affect the validity of the whole or any part of this Agreement or prejudice such Party’s right to take subsequent action. No single or partial exercise of any right, power, or privilege granted under this Agreement shall preclude any other or further exercise thereof or the exercise of any other right, power, or privilege. Except as expressly set forth in this Agreement, the rights and remedies provided in this Agreement are cumulative and are not exclusive of any rights or remedies provided by law or in any other agreement between the Parties.
8.6Notices and Other Communications. All notices, consents, approvals, requests, and other communications required or permitted under this Agreement (each a “Notice”) shall refer to this Agreement, must be in writing and delivered personally or by recognized overnight courier and will be deemed given, if addressed as provided herein: (a) when delivered personally, upon delivery; or (b) when sent by recognized overnight courier, upon written confirmation of delivery or receipt. All such Notices shall be addressed to such Party at the address given below or to such other address as a Party may designate by Notice delivered in accordance with this Section 8.6.
If to Netlist:
Netlist, Inc.
111 Academy Way, Suite 100
Irvine, CA 92617
Attention: Richard Kim, Vice President of IP Strategy
Email: [***]
If to Samsung:
Samsung Electronics Co., Ltd.
1-1, Samsungjeonja-ro, Hwaseong-si
Gyeonggi-do, 18448 Korea
Attention: Inseong Na, Head of Licensing Group
Email: [***]
8.7Confidentiality of Terms. Either Party may disclose the existence of this Agreement, but neither Party shall (and each Party shall ensure that none of its Affiliates and its and their agents, employees, or representatives shall) disclose the terms of this Agreement to any Third Party without the prior written consent of the other Party, except that each Party may disclose the terms of this Agreement (a) to any of its Affiliates on terms consistent with this Section 8.7; (b) to any governmental authority having jurisdiction and requiring such disclosure; (c) in response to a valid subpoena or as may otherwise be required by law, (d) for the purposes of disclosure in connection with the Securities Exchange Act of 1934, as amended, the Securities Act of 1933, as
6
amended, and any other reports filed with the Securities and Exchange Commission, or any other filings, reports, or disclosures that may be required under applicable laws or regulations or the rules of any stock exchange on which the securities of such Party may be listed, (e) in confidence to Auditor and such Party’s accountants, legal counsel, tax advisors, and other financial and legal advisors; (f) as required during the course of litigation or for purposes of recording or evidencing the licenses and other rights conveyed hereunder; (g) on terms consistent with this Section 8.7, to another Person or its legal or financial advisors in connection with an actual or proposed merger, acquisition, spin-off, financing, patent sale, patent license, or similar transaction involving such Person and the Party or any of its Affiliates; (h) to its and its Affiliates’ direct and indirect suppliers, distributors, resellers, customers, and users of any Licensed Products, to the extent necessary to demonstrate the licenses and other rights conveyed hereunder; or (i) with the prior written consent of the other Party; provided, however, that the Party making or seeking any disclosure will take commercially reasonable actions to minimize the nature and extent of such disclosure.
8.8Publicity. Neither Party shall (and shall ensure that none of its Affiliates and its and their agents, employees, and representatives shall) originate any publicity, news release, or other public announcement, written or oral, relating to this Agreement without the prior written approval of the other Party except as otherwise required by law or permitted pursuant to Section 8.7. Notwithstanding the foregoing, nothing in this Section 8.8 shall prevent or prohibit, or be construed to require approval by any Party for, (a) any publicity, news release, or other public announcement of information that is or becomes available to the general public other than in violation of the confidentiality provisions of this Agreement, or (b) any disclosure permitted pursuant to Section 8.7 or the confidentiality provisions of this Agreement, provided that any press release or other public announcement relating to this Agreement, other than disclosures under Sections 8.7(d) and 8.8(a), shall be issued only in the form and contents mutually agreed in writing by both Parties prior to such press release or public announcement.
8.9Bankruptcy. The Parties acknowledge and agree that the licenses and other rights granted under this Agreement are conveyed and effective when granted and that each Party and its Affiliates are entitled to the maximum protection of those licenses and other rights under applicable law, including the right to preserve and enforce the benefits set forth in this Agreement.
Without limiting the generality of the foregoing, the licenses granted hereunder are licenses to rights in “intellectual property” within the meaning of Section 365(n) of the U.S. Bankruptcy Code, and each Party and its Affiliates may fully exercise all rights and elections available under Section 365(n) of the U.S. Bankruptcy Code, the bankruptcy laws of any other country, or this Agreement.
8.10Single Portfolio License. The Parties acknowledge and agree that the License Fees and the other terms of this Agreement have been negotiated and agreed upon for the convenience of the Parties as a single portfolio-wide license under the Licensed Patents taken as a whole, and not on a per-Patent basis. Accordingly, neither the License Fees nor any other term of this Agreement shall be subject to any reduction, adjustment, offset, recalculation, refund, or credit, and no payment obligation shall be excused or diminished, as a result of any one or more of the Licensed Patents (or any claim thereof) expiring, being abandoned, or being held or determined to be invalid, unenforceable, or not infringed, or otherwise ceasing to be in force or enforceable, at any time during the License Term.
7
8.11Entire Agreement; Amendment. This Agreement, together with any other written agreements duly executed by the Parties concurrently herewith, constitute the full and entire understanding and agreement between the Parties with regard to the subject matter hereof, and supersedes any communications, representations, understandings, and agreements, either oral or written, between the Parties prior to the Effective Date with respect to such subject matter. For the avoidance of doubt, no right or obligation in this Agreement is conditioned upon the performance of any purported obligation in any oral or written agreement other than this Agreement. [***]. Any waiver or amendment of the provisions of this Agreement or of a Party’s rights or remedies under this Agreement must be in writing and signed by an authorized legal representative of each Party to be effective.
8.12Non-Reliance. Each Party agrees that, in entering into this Agreement, (a) it has solely relied on the results of its own investigation of the facts and circumstances, its own business judgment, and the express terms and conditions in this Agreement, and (b) it has not relied upon and is not entitled to rely on any oral or written understanding, condition, representation, warranty, or communication of the other Party in entering into this Agreement except for those expressly set forth herein. Each Party acknowledges that it is sophisticated and has been represented by counsel during the negotiation and execution of this Agreement.
8.13Construction. This Agreement shall be deemed to have been drafted by both Parties, and neither Party shall be entitled to claim that any provision should be construed against the other Party by reason of the fact that it was drafted by the other Party. The words “hereof,” “herein,” “hereunder,” and similar words refer to this Agreement as a whole and not to any particular provision of this Agreement. The term “including” is not limited and means “including without limitation.” Unless otherwise noted, all references to Sections and Schedules herein are to Sections and Schedules of this Agreement. The titles, captions, and headings of this Agreement are inserted for convenience of reference only and are not intended to be a part of, or to affect the meaning or interpretation of, this Agreement. Unless otherwise expressly provided herein, (a) references to a Person include its successors and permitted assigns, (b) references to agreements (including this Agreement) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, supplements, and other modifications and additions thereof and thereto, and (c) references to any statute or regulation are to be construed as including all statutory and regulatory provisions consolidating, amending, replacing, supplementing, or interpreting such statute or regulation.
8.14Severability. If any provision in this Agreement is found or held to be invalid or unenforceable, then the meaning of such provision will be construed, to the extent feasible, so as to render the provision enforceable and still achieve the Parties’ intent in entering into this Agreement, and if no feasible interpretation would save such provision, it will be severed from the remainder of this Agreement, which will remain in full force and effect. In such event, the Parties will use all reasonable efforts to negotiate in good faith a substitute valid and enforceable provision or agreement that most nearly effects the Parties’ intent in entering into this Agreement.
8.15Counterparts. This Agreement may be executed in counterparts, each of which so executed will be deemed to be an original and such counterparts together will constitute one and the same agreement. Execution and delivery of this Agreement by exchange of facsimile
8
copies or “pdf’ files bearing the facsimile signature of a Party shall constitute a valid and binding execution and delivery of this Agreement by such Party.
[Signature page follows]
9
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.
| NETLIST, INC. | |
| | |
| | |
| By: | /s/ Chun K. Hong |
| | Name: Chun K. Hong |
| | Title: Chief Executive Officer |
| | |
| | Date: August 4, 2026 |
| | |
| | |
| SAMSUNG ELECTRONICS CO., LTD. | |
| | |
| | |
| By: | /s/ Yong Kwan Kim |
| | Name: Yong Kwan Kim |
| | Title: Corporate President, Device Solutions |
| | |
| | Date: August 4, 2026 |
10
SCHEDULE A
[***]
11
SCHEDULE B
[***]
12
Exhibit 10.4
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
SETTLEMENT AND RELEASE AGREEMENT
This Settlement and Release Agreement (this “Agreement”) is made and entered into as of July 31, 2026 (the “Effective Date”) by and between Netlist, Inc., a Delaware corporation having its principal place of business at 111 Academy Way, Suite 100, Irvine, CA 92617 (“Netlist”), and Samsung Electronics Co., Ltd., acting through Device Solutions, a company existing under the laws of the Republic of Korea, with its place of business at 1-1, Samsungjeonja-ro, Hwaseong-si, Gyeonggi-do, 18448 Korea (“Samsung”).
RECITALS
WHEREAS, Netlist and Samsung are currently involved in certain pending legal actions in various fora as identified in Schedule 1 hereto (collectively, the “Pending Proceedings”);
WHEREAS, concurrently with this Agreement the Parties are entering into a Patent Cross License Agreement (the “PXL”) pursuant to which each Party grants the other a license under its Captured Patents;
WHEREAS, the Parties now wish to settle, dismiss, withdraw from, terminate, and cease to support (as applicable) the Pending Proceedings, and to grant each other the releases set forth herein, in each case without any admission of liability or acquiescence by either Party, and otherwise agree as set forth in, and pursuant to the terms and conditions of, this Agreement; and
WHEREAS, in addition to resolving the matters between the Parties, the Parties acknowledge a mutual interest in exploring potential technology collaboration opportunities and may, from time to time, engage in discussions regarding such opportunities as they mutually determine to be appropriate.
NOW, THEREFORE, in consideration of the mutual covenants, agreements, releases, and other rights and obligations set forth herein, the Parties hereby agree as follows:
AGREEMENT
1.DEFINITIONS
1.1Defined Terms. Capitalized terms, when used in this Agreement, have the meaning ascribed to them in this Section 1.1 or elsewhere in this Agreement.
1.1.1“Affiliate” means, with respect to a Person, any other Person that now or at any time thereafter during the Capture Period directly or indirectly Controls, is Controlled by, or is under common Control with that Person, where “Control” means ownership
of more than fifty percent (50%) of the capital or voting stock, or equivalent ownership interests, of such Person. A Person is an “Affiliate” only as long as such Control exists.
1.1.2[***]
1.1.3“Captured Patents” means (a) with respect to Netlist, all Patents owned or otherwise licensable or enforceable by Netlist or its Affiliates on the Effective Date or at any time thereafter during the Capture Period, and (b) with respect to Samsung, [***].
1.1.4“PXL” is defined in the Recitals.
1.1.5“Party” means each of Netlist and Samsung, individually, and “Parties” means Netlist and Samsung, collectively.
1.1.6“Patents” means, throughout the world, all classes and types of patents, inventor’s certificates, utility models, and similar rights, and all applications, provisional applications, and registrations for any of the foregoing.
1.1.7“Pending Proceedings” has the meaning set forth in the Recitals.
1.1.8“Person” means any person or entity, whether an individual, corporation, partnership, limited partnership, limited liability company, trust, foundation, unincorporated organization, business association, firm, joint venture, or other legal entity.
1.1.9“Third Party” means any Person that is neither a Party nor an Affiliate of a Party.
1.1.10“Upfront Payment” means [***] upfront license fee as set forth in the PXL.
2.DISMISSAL AND WITHDRAWAL OF PENDING PROCEEDINGS
2.1Dismissal. Subject to Section 2.3, [***], the Parties shall stipulate to dismiss the Pending Proceedings, to the extent possible, including by executing and filing with the applicable courts and government agencies stipulated motions for orders dismissing the applicable Pending Proceedings with prejudice.
2.2Withdrawal and Termination. Subject to Section 2.3, with respect to any Patent Trial and Appeal Board (PTAB), International Trade Commission (ITC), and other Pending Proceedings that cannot be dismissed by the Parties, the Parties shall terminate, withdraw from, or cease to support such Pending Proceedings, except to the extent otherwise compelled to do so by legal process. Where a Pending Proceeding continues despite Samsung’s dismissal or withdrawal (for example, because one or more Third Parties remain involved), including pursuant to Section 2.3, Netlist may continue its involvement in such Pending Proceeding (for example, certain appeals before the U.S. Court of Appeals for the Federal Circuit) to preserve, defend, and enforce its rights, but Samsung shall not continue to support, or assist any Third Party to support, such Pending Proceeding in any manner unless compelled to do so by legal process.
2
2.3Proceedings Continued by Netlist. Notwithstanding anything to the contrary in Section 2.1 or Section 2.2, Netlist will not be required to, and will not, dismiss any Pending Proceedings or terminate its participation in and support of any Pending Proceedings, including any appeals, that involve any potential invalidation or revocation or nullification or finding of unpatentability of any Netlist’s Patents, or in which Netlist is asserting infringement of Patents against any Third Party which assertions are not released under Section 3.1. This Section shall not be applicable to the Pending District Court Cases (but only with respect to Samsung, its Affiliates, and/or assertions against their respective products) and Pending ITC Investigations as listed in Schedule 1.
2.4Further Action. Each Party shall promptly execute such other documents and take such other steps as may be reasonably requested by the other Party to give effect to the foregoing and the other provisions of this Agreement.
2.5No Admission. This Agreement is entered into in order to resolve disputed claims and proceedings without further litigation. Neither Party makes, and nothing in this Agreement constitutes or shall be construed as, any admission or concession by either Party or its Affiliates of infringement, non-infringement, validity, or invalidity of any Patents, or any acquiescence as to the merit of any claim, liability, or damages related to any Patents or the Pending Proceedings. Neither this Agreement nor any part hereof shall be, or shall be used as, or as evidence of, an admission of infringement, non-infringement, validity, or invalidity of any Patents, or any claim, liability, or damages, at any time for any purpose, except for any claim to enforce the provisions of this Agreement.
3.RELEASE
3.1Release by Netlist. Subject to compliance with Section 2 and subject to Section 3.3, in consideration of the mutual releases and other covenants hereunder, effective upon the Effective Date, Netlist, on behalf of itself and its Affiliates, hereby irrevocably releases, acquits, and forever discharges Samsung and its Affiliates, and their respective employees, directors, officers, agents, and representatives, each in their capacity as such, and their respective customers (but only with respect to their use, sale, offer for sale or importation of products purchased from Samsung or its Affiliates before the Effective Date, which products would be licensed under the PXL had they been sold after the Effective Date), from any and all claims and liabilities (a) for infringement of any of Netlist’s Captured Patents, with respect to any act occurring before the Effective Date, to the extent the same would have been licensed under the PXL had such act occurred after the Effective Date, and (b) otherwise asserted in or arising from the Pending Proceedings.
3.2Release by Samsung. Subject to compliance with Section 2, in consideration of the mutual releases and other covenants hereunder, effective upon the Effective Date, Samsung, on behalf of itself and its Affiliates, hereby irrevocably releases, acquits, and forever discharges Netlist and its Affiliates, and their respective, employees, directors, officers, agents, and representatives, each in their capacity as such, and their respective customers (but only with respect to their use, sale, offer for sale or importation of products purchased from Netlist or its Affiliates before the Effective Date, which products would be licensed under the PXL had they been sold after the Effective Date), from any and all claims and liabilities (a) for infringement of any of
3
Samsung’s Captured Patents, with respect to any act occurring before the Effective Date, to the extent the same would have been licensed under the PXL had such act occurred after the Effective Date, and (b) otherwise asserted in or arising from the Pending Proceedings.
3.3[***]
3.4[***]
3.5Discharge of Verdicts and Judgments. Subject to compliance with Section 2, effective upon the Effective Date, the releases granted under this Agreement shall be deemed to fully satisfy and discharge any and all outstanding verdicts, judgments, and any amounts that may arise therefrom, including those currently subject to appeal, with respect to the Pending Proceedings.
4.ASSIGNMENT AND SUCCESSORS
4.1Assignment. Neither Party may assign, delegate, or otherwise transfer this Agreement or any of its rights or obligations hereunder without the other Party’s prior written consent, [***]. Any purported assignment in violation of this Section 4.1 will be null and void. Subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns. Nothing in this Agreement will limit a Party’s right and ability to transfer or otherwise dispose of its Patents, subject to the releases and other rights granted hereunder.
4.2Successors and Assigns. Subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns.
5.REPRESENTATIONS AND WARRANTIES
5.1General Representations. Each Party represents and warrants that (a) it has all requisite corporate power and authority to execute and deliver this Agreement and to carry out the provisions of this Agreement on its own behalf and on behalf of its Affiliates, (b) the execution, delivery, and performance by such Party of this Agreement have been approved by all requisite action on the part of such Party, and no other proceedings, approvals, consents, authorizations, or other acts on the part of such Party are necessary to authorize this Agreement, (c) such Party’s execution, delivery, and performance of this Agreement do not and will not conflict with, violate, or result in any breach of any relevant law or any provision of any license, agreement, contract, understanding, arrangement, commitment, or undertaking of any nature (whether written or oral) to which such Party is a party or by which such Party is otherwise bound.
5.2Additional Representations. Each Party further represents and warrants that:
5.2.1It has the full right, power, and authority to grant the releases and discharges granted by it under this Agreement, and such releases and discharges are valid, effective, and enforceable in accordance with their terms.
4
5.2.2It has not assigned, transferred, or otherwise conveyed to any other Person any claims or liabilities released by it under this Agreement.
5.2.3[***]
6.MISCELLANEOUS
6.1Relationship of the Parties. In the exercise of their respective rights and the performance of their respective obligations hereunder, the Parties are and will remain independent contractors. Nothing in this Agreement will be construed to constitute the Parties as partners, or principal and agent, for any purpose whatsoever. Neither Party will bind, or attempt to bind, the other Party to any contract or other obligation, and neither Party will represent to any Third Party that it is authorized to act on behalf of the other Party.
6.2Governing Law. This Agreement will be governed by and construed in accordance with the laws of [***] (without application of any choice or conflict of laws rules or principles that would require the application of the laws of any other jurisdiction).
6.3Venue. Each Party (a) hereby irrevocably submits itself to and consents to the jurisdiction of the state and federal courts located in [***] for the purposes of any action, claim, suit, or proceeding in connection with any controversy, claim, or dispute arising out of this Agreement, and (b) hereby waives, and agrees not to assert, by way of motion, as a defense or otherwise, in any such action, claim, suit or proceeding, any claim that it is not personally subject to the jurisdiction of such court(s), that the action, claim, suit or proceeding is brought in an inconvenient forum or that the venue of the action, claim, suit or proceeding is improper. Notwithstanding the foregoing, each Party may bring any legal, administrative, or regulatory proceeding in any court or other forum of competent jurisdiction anywhere in the world under or with regard to any Patents (subject to the releases, licenses, covenants, and other rights under this Agreement and the PXL). For clarity, subject to the releases and dismissals pursuant to Sections 2 and 3, nothing in this Agreement shall limit the Parties’ ability to file petitions for inter partes review, ex parte review, reexamination, nullity actions, or any other similar reissue or post grant procedures in any forum of competent jurisdiction anywhere in the world concerning any Patent.
6.4No Waiver. The waiver by either Party of a breach or default of any provision of this Agreement by the other Party will not be construed as a waiver of any succeeding breach of the same or any other provision, nor will any delay or omission on the part of either Party to exercise or avail itself of any right, remedy, power, or privilege that it has or may have hereunder operate as a waiver of any right, remedy, power, or privilege by such Party and will not in any way affect the validity of the whole or any part of this Agreement or prejudice such Party’s right to take subsequent action. No single or partial exercise of any right, power, or privilege granted under this Agreement shall preclude any other or further exercise thereof or the exercise of any other right, power, or privilege. Except as expressly set forth in this Agreement, the rights and remedies provided in this Agreement are cumulative and are not exclusive of any rights or remedies provided by law or in any other agreement between the Parties.
6.5Notices and Other Communications. All notices, consents, approvals, requests, and other communications required or permitted under this Agreement (each a “Notice”)
5
shall refer to this Agreement, must be in writing and delivered personally or by recognized overnight courier and will be deemed given, if addressed as provided herein: (a) when delivered personally, upon delivery; or (b) when sent by recognized overnight courier, upon written confirmation of delivery or receipt. All such Notices shall be addressed to such Party at the address given below or to such other address as a Party may designate by Notice delivered in accordance with this Section 6.5..
If to Netlist:
Netlist, Inc.
111 Academy Way, Suite 100
Irvine, CA 92617
Attention: Richard Kim, Vice President of IP Strategy
Email: [***]
If to Samsung:
Samsung Electronics Co., Ltd.
1-1, Samsungjeonja-ro, Hwaseong-si
Gyeonggi-do, 18448 Korea
Attention: Inseong Na, Head of Licensing Group
Email: [***]
6.6Severability. If any provision in this Agreement is found or held to be invalid or unenforceable, then the meaning of such provision will be construed, to the extent feasible, so as to render the provision enforceable and still achieve the Parties’ intent in entering into this Agreement, and if no feasible interpretation would save such provision, it will be severed from the remainder of this Agreement, which will remain in full force and effect. In such event, the Parties will use all reasonable efforts to negotiate in good faith a substitute valid and enforceable provision or agreement that most nearly effects the Parties’ intent in entering into this Agreement.
6.7Confidentiality of Terms. Either Party may disclose the existence of this Agreement, but neither Party shall (and each Party shall ensure that none of its Affiliates and its and their agents, employees, or representatives shall) disclose the terms of this Agreement to any Third Party without the prior written consent of the other Party, except that each Party may disclose the terms of this Agreement (a) to any of its Affiliates on terms consistent with this Section 6.7; (b) to any governmental authority having jurisdiction and requiring such disclosure; (c) in response to a valid subpoena or as may otherwise be required by law, (d) for the purposes of disclosure in connection with the Securities Exchange Act of 1934, as amended, the Securities Act of 1933, as amended, and any other reports filed with the Securities and Exchange Commission, or any other filings, reports, or disclosures that may be required under applicable laws or regulations or the rules of any stock exchange on which the securities of such Party may be listed, (e) in confidence to such Party’s accountants, legal counsel, tax advisors, and other financial and legal advisors; (f) as required during the course of litigation or for purposes of recording or evidencing the releases and other rights conveyed hereunder; (g) on terms consistent with this Section 6.7, to another Person or its legal or financial advisors in connection with an actual or proposed merger,
6
acquisition, spin-off, financing, patent sale, patent license, or similar transaction involving such Person and the Party or any of its Affiliates; (h) to its and its Affiliates’ direct and indirect suppliers, distributors, resellers, customers, and users to the extent necessary to demonstrate the releases and other rights conveyed hereunder; or (i) with the prior written consent of the other Party; provided, however, that the Party making or seeking any disclosure will take commercially reasonable actions to minimize the nature and extent of such disclosure.
6.8Publicity. Neither Party shall (and shall ensure that none of its Affiliates and its and their agents, employees, and representatives shall) originate any publicity, news release, or other public announcement, written or oral, relating to this Agreement without the prior written approval of the other Party except as otherwise required by law or permitted pursuant to Section 6.7. Notwithstanding the foregoing, nothing in this Section 6.8 shall prevent or prohibit, or be construed to require approval by any Party for, (a) any publicity, news release, or other public announcement of information that is or becomes available to the general public other than in violation of the confidentiality provisions of this Agreement, or (b) any disclosure permitted pursuant to Section 6.7 or the confidentiality provisions of this Agreement, provided that any press release or other public announcement relating to this Agreement, other than disclosures under Sections 6.7(d) and 6.8(a), shall be issued only in the form and contents mutually agreed in writing by both Parties prior to such press release or public announcement.
6.9Bankruptcy. The Parties acknowledge and agree that the releases and other rights granted under this Agreement are conveyed and effective when granted and that each Party and its Affiliates are entitled to the maximum protection of those releases and other rights under applicable law, including the right to preserve and enforce the benefits set forth in this Agreement. Without limiting the generality of the foregoing, the releases and other rights granted hereunder are rights in “intellectual property” within the meaning of Section 365(n) of the U.S. Bankruptcy Code, and each Party and its Affiliates may fully exercise all rights and elections available under Section 365(n) of the U.S. Bankruptcy Code, the bankruptcy laws of any other country, or this Agreement.
6.10Entire Agreement; Amendment. This Agreement, together with any other written agreements duly executed by the Parties concurrently herewith, constitute the full and entire understanding and agreement between the Parties with regard to the subject matter hereof, and supersedes any communications, representations, understandings, and agreements, either oral or written, between the Parties prior to the Effective Date with respect to such subject matter. For the avoidance of doubt, no right or obligation in this Agreement is conditioned upon the performance of any purported obligation in any oral or written agreement other than this Agreement. [***]. Any waiver or amendment of the provisions of this Agreement or of a Party’s rights or remedies under this Agreement must be in writing and signed by an authorized legal representative of each Party to be effective.
6.11Non-Reliance. Each Party agrees that, in entering into this Agreement, (a) it has solely relied on the results of its own investigation of the facts and circumstances, its own business judgment, and the express terms and conditions in this Agreement, and (b) it has not relied upon and is not entitled to rely on any oral or written understanding, condition, representation, warranty, or communication of the other Party in entering into this Agreement except for those
7
expressly set forth herein. Each Party acknowledges that it is sophisticated and has been represented by counsel during the negotiation and execution of this Agreement.
6.12Construction. This Agreement shall be deemed to have been drafted by both Parties and, neither Party shall be entitled to claim that any provision should be construed against the other Party by reason of the fact that it was drafted by the other Party. The words “hereof,” “herein,” “hereunder,” and similar words refer to this Agreement as a whole and not to any particular provision of this Agreement. The term “including” is not limited and means “including without limitation.” Unless otherwise noted, all references to Sections and Schedules herein are to Sections and Schedules of this Agreement. The titles, captions, and headings of this Agreement are inserted for convenience of reference only and are not intended to be a part of, or to affect the meaning or interpretation of, this Agreement. Unless otherwise expressly provided herein, (a) references to a Person include its successors and permitted assigns, (b) references to agreements (including this Agreement) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, supplements, and other modifications and additions thereof and thereto, and (c) references to any statute or regulation are to be construed as including all statutory and regulatory provisions consolidating, amending, replacing, supplementing, or interpreting such statute or regulation.
6.13Counterparts. This Agreement may be executed in counterparts, each of which so executed will be deemed to be an original and such counterparts together will constitute one and the same agreement. Execution and delivery of this Agreement by exchange of facsimile copies or “pdf” files bearing the facsimile signature of a Party shall constitute a valid and binding execution and delivery of this Agreement by such Party.
[Signature page follows]
8
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.
| NETLIST, INC. | |
| | |
| | |
| By: | /s/ Chun K. Hong |
| | Name: Chun K. Hong |
| | Title: Chief Executive Officer |
| | |
| | Date: August 4, 2026 |
| | |
| | |
| SAMSUNG ELECTRONICS CO., LTD. | |
| | |
| | |
| By: | /s/ Yong Kwan Kim |
| | Name: Yong Kwan Kim |
| | Title: Corporate President, Device Solutions |
| | |
| | Date: August 4, 2026 |
9
Schedule 1
Pending Proceedings
Pending Appeals
CAFC case no. 24-1707, appeal of IPR2022-00639 of U.S. 10,949,339
CAFC case no. 24-1859, appeal of IPR2022-00996 of U.S. 11,016,918
CAFC case no. 24-1863, appeal of IPR2022-00999 of U.S. 11,232,054
CAFC case no. 24-2203, appeal of EDTX case no. 2:21-cv-00463
CAFC case no. 24-2240, appeal of IPR2022-01427 of U.S. 9,318,160
CAFC case no. 24-2241, appeal of IPR2022-01428 of U.S. 8,787,060
CAFC case no. 24-2304, appeal of IPR2022-00615 of U.S. 7,619,912
CAFC case no. 25-1286, appeal of IPR2023-00455 of U.S. 9,858,215
CAFC case no. 25-1296, appeal of IPR2023-00454 of U.S. 11,093,417
CA9 case no. 25-5531, appeal of CDCA case no. 8:20-cv-00993
Federal Court of Justice Docket No. X ZR 17/25 (EP ‘660)
Federal Court of Justice Docket No. X ZR 47/24 (EP ‘735)
Pending District Court Cases
DDE case no. 1:21-cv-01453
EDTX case no. 2:22-cv-00293
DDE case no. 1:23-cv-01122
DDE case no. 1:24-cv-00614
EDTX case no. 2:25-cv-00557
DDE case no. 1:25-cv-00626
EDTX case no. 2:25-cv-00748
DDE case no. 1:25-cv-01371
DDE case no. 1:25-cv-01589
EDTX case no. 2:26-cv-00441
EDTX case no. 2:26-cv-00456
EDTX case no. 2:26-cv-00553
DDE case no. 1:26-cv-00821
Dusseldorf District Court Docket No. 4a O 55/25 (EP ‘660)
Dusseldorf District Court Docket No. 4a O 31/26 (EP ‘735)
Pending ITC Investigations
ITC Investigation No. 337-TA-1472
ITC Investigation No. 337-TA-1511
Pending AIA Challenges
1PR2025-01431 of U.S. 10,025,731 PGR2026-00001 of U.S. 12,373,366
Samsung not to seek Director Review of or otherwise challenge, denial of institution.
10
IPR2026-00018 of U.S. 12,373,366
Samsung not to seek Director Review of or otherwise challenge, denial of institution.
Pending Ex Parte Reexaminations
Appl. No. 90/016,022 of U.S. 9,824,035
Appl. No. 90/016,140 of U.S. 12,373,366
App1. No. 90/016,141 of U.S. 12,373,366
11
Exhibit 10.5
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
Supply Agreement
This Supply Agreement (“Supply Agreement”) is made effective as of July 31, 2026 (the “Effective Date”), by and between Netlist, Inc., a Delaware corporation, having its principal place of business at 111 Academy Way, Suite 100, Irvine, CA 92617 (“Netlist” or “Purchaser”) and Samsung Semiconductor, Inc., a California corporation, having offices at 3655 North First Street, San Jose, CA 95126 (“Samsung” or “Supplier”). Each of Purchaser and Supplier is referred to as a “Party” and collectively the “Parties”.
1. | Term | The term of this Supply Agreement shall commence on the Effective Date and shall continue for a period of five (5) years, unless earlier terminated in accordance with Section 8 (Termination) hereunder (the “Term”). |
2. | Product(s) and Annual Cap | In each year of the Term, Purchaser has the right to purchase and Supplier shall supply, as ordered by Purchaser, the following DRAM and NAND product(s) (the “Product(s)”), subject to the limitations noted below, including the Annual Cap, [***]: [***] Annual Cap: The purchase and supply of the Product(s) in each year during the Term shall be capped at Three Hundred Million U.S. Dollars ($300M) (“Annual Cap”), totaling One Billion Five Hundred Million U.S. Dollars ($1.5B) by the end of the Term. [***] |
3. | [***] | [***] |
4. | [***] | [***] |
5. | Limited Warranty and Remedy | Supplier warrants that DRAM Product(s) will materially conform to the applicable specifications for [***] from the date of shipment from Supplier’s designated shipping facility or [***] (the “Warranty Period”). This warranty does not cover any defects that have been caused by (a) misuse, abuse, neglect, or accident; (b) unauthorized modification, alteration, or repair; (c) improper installation, storage, handling, or operation; (d) use in environments or applications not specified or recommended by Supplier; (e) electrostatic discharge or power surges; (f) use with non-compatible components or systems; or (g) normal wear and tear. Supplier’s sole obligation, and Purchaser’s sole and exclusive remedy, for breach of the warranty in this section shall be, at Supplier’s sole option, to (a) repair the nonconforming Product(s), (b) replace the |
| | nonconforming Product(s), or (c) provide a credit memo for the Product Price(s) of the nonconforming Product(s). The foregoing remedies are Purchaser’s sole and exclusive remedies and Supplier’s entire liability for any breach of warranty. | |||
6. | Disclaimer and Limitation of Liabilities | EXCEPT FOR THE EXPRESS LIMITED WARRANTY SET FORTH IN SECTION 5, SUPPLIER MAKES NO WARRANTIES OF ANY KIND, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT, QUALITY, ACCURACY, OR COMPLETENESS. ANY CLAIM OR ADJUDICATION THAT THE PRODUCT(S) INFRINGE ANY PROPRIETARY RIGHTS OF A THIRD PARTY SHALL NOT CONSTITUTE A BREACH OF THIS SUPPLY AGREEMENT OR GROUND FOR TERMINATION OF THIS SUPPLY AGREEMENT BY PURCHASER. IN NO EVENT SHALL SUPPLIER BE LIABLE TO PURCHASER OR ANY THIRD PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION DAMAGES FOR LOST PROFITS, LOST REVENUE, LOST BUSINESS OPPORTUNITIES, LOSS OF DATA, LOSS OF GOODWILL, BUSINESS INTERRUPTION, COST OF PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, OR ANY OTHER PECUNIARY LOSS, ARISING OUT OF OR RELATING TO THIS SUPPLY AGREEMENT AND/OR THE PRODUCT(S), REGARDLESS OF THE THEORY OF LIABILITY (WHETHER IN CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR OTHERWISE) AND REGARDLESS OF WHETHER SUPPLIER HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. EXCEPT FOR (A) EITHER PARTY’S BREACH OF SECTION 9 (CONFIDENTIALITY), AND (B) PURCHASER’S PAYMENT OBLIGATIONS UNDER THIS SUPPLY AGREEMENT, EACH PARTY’S TOTAL AGGREGATE LIABILITY HOWSOEVER ARISING OUT OF OR RELATING TO THIS SUPPLY AGREEMENT AND/OR THE PRODUCT(S), WHETHER IN CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR OTHERWISE, SHALL NOT EXCEED THE TOTAL AMOUNTS PAID OR PAYABLE BY NETLIST TO SUPPLIER FOR PRODUCTS AT ISSUE IN THE CLAIM DURING THE TWELVE (12) MONTHS IMMEDIATELY PRECEDING THE CLAIM. | |||
7. | Force Majeure | “Force Majeure Event” means any event or cause beyond the reasonable control of Supplier that affects Supplier’s ability to perform its obligations under this Supply Agreement, including without limitation: | |||
2
| | (a) acts of God or public enemy, fire, flood, earthquake, typhoon, epidemic, pandemic, or environmental or safety accidents; (b) war, blockade, riot, terrorism, civil disturbance, or civil unrest; (c) strike, lockout, labor disputes, or other labor difficulties; (d) embargo, export controls, sanctions, changes in or imposition of trade restrictions, tariffs, import/export regulations, or technology transfer controls, or acts of civil, judicial, or military authorities; and (d) any other cause beyond the reasonable control of Supplier; provided, however, Supplier shall (i) immediately notify the Purchaser in writing when the cause of such excuse occurs, (ii) immediately use its commercially reasonable efforts to resume it performance in full, (iii) continue at all times to perform whenever and to the extent reasonably possible. Supplier shall not be liable for any loss or damage resulting from any failure or delay in performing, or failure to comply with, its obligations under this Supply Agreement to the extent that such failure, delay, or non-compliance results from a Force Majeure Event. During the continuance of a Force Majeure Event, Supplier’s affected obligations hereunder shall be suspended without liability. For the avoidance of doubt, Purchaser’s payment obligations and purchase obligations shall not be excused by any Force Majeure Event or by any event, condition, or circumstance affecting Purchaser, regardless of whether such event would otherwise constitute a Force Majeure Event if it affected Supplier, provided, however, that those obligations shall be excused only to the extent they relate to the Products and quantities that Supplier is excused from supplying as a result of such Force Majeure Event. |
8. | [***] | [***] |
9. | [***] | [***] |
10. | General Provisions | [***] Governing Law and Dispute Resolution: This Supply Agreement shall be governed by and construed in accordance with the laws of the [***] without regard to its conflict of laws provisions and as if entirely performed therein. [***]. Entire Agreement; Modifications: This Supply Agreement constitutes the entire understanding between the Parties and supersedes and cancels all prior agreements, express or implied, written or oral, with respect to the subject matter hereof. This Supply Agreement may be modified, but only by a written agreement executed in the same manner as this Supply Agreement. |
3
IN WITNESS WHEREOF, the Parties hereto have caused this Supply Agreement to be executed as of the Effective Date by their duly authorized representatives.
Purchaser: | | Supplier: | ||
| | | ||
Netlist, Inc. | | Samsung Semiconductor, Inc. | ||
| | | ||
By: | /s/ Gail Sasaki | | By: | /s/ Sang-jin Oh |
| Name: Gail Sasaki | | | Name: Sang-jin Oh |
| Title: Chief Financial Officer | | | Title: Chief Financial Officer |
| | | | |
Date: August 3, 2026 | | Date: August 4, 2026 | ||
4
Exhibit 10.6
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
ITC Cooperation Agreement
This ITC Cooperation Agreement (“Agreement”) is made effective as of July 31, 2026 (the “Effective Date”), by and between Netlist, Inc., having its principal place of business at 111 Academy Way, Suite 100, Irvine, CA 92617 (“Netlist”) and Samsung Electronics Co., Ltd., acting through Device Solutions, a company existing under the laws of the Republic of Korea, with its place of business at 1-1, Samsungjeonja-ro, Hwaseong-si, Gyeonggi-do, 18448 Korea (“Samsung”). (Each of Netlist and Samsung is referred to as a “Party” and collectively the “Parties”).
RECITALS
WHEREAS, Netlist anticipates that it may serve one or more subpoenas or other discovery requests (“Discovery Request(s)”) upon Samsung or its directly or indirectly owned subsidiaries seeking documents or information in connection with certain ITC investigations pursued by Netlist;
WHEREAS, any materials that Samsung may provide in response will be produced solely in compliance with, and to the extent required by, the applicable rules of procedure and evidence and any order or process of the courts; and
WHEREAS, Samsung does not waive, and expressly preserves, all rights, objections, privileges, and protections available to it under applicable law with respect to any Discovery Request, and the Parties wish to set forth the terms under which Samsung will respond to any such Discovery Request.
NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, the Parties agree as follows:
Section 1.DEFINITIONS
[***]
Section 2.SCOPE
2.1Production of Documents: Upon request by Netlist, [***], during the Term of this Agreement, Samsung or its affiliate agrees to produce or provide certain information, documents, and declarations (“Samsung Documents”) in response to such request, as follows, to Netlist for use in [***] ITC investigations brought by Netlist (“ITC Investigation(s)”), [***].
2.2Scope of Production: Subject to the conditions in Section 2.1 and 2.3, Samsung Documents include the following:
1)Reasonably available materials in Samsung’s possession, custody or control regarding Samsung’s products licensed under an applicable license agreement between Samsung and Netlist in the United States, [***];
2)Deposition transcripts and/or materials from earlier litigation matters and ITC investigations involving Netlist, [***];
3)Declarations of the relevant Samsung entities as necessary to authenticate any materials produced by Samsung pursuant to this Agreement. [***].
2.3[***]
Section 3.Outside Counsel’s Eyes Only
3.1Samsung Documents shall be deemed Highly Confidential — Outside Counsel’s Eyes Only (or similar designation). Upon receipt, Netlist shall be bound by the operative ITC Administrative Protective Order (“APO”) issued in the investigation for which Samsung Documents are produced. [***] any production or filing of Samsung Documents by Netlist shall maintain the aforementioned confidentiality designation subject to the APO.
3.2Netlist shall take all necessary measures to ensure that Samsung Documents are shielded from public disclosure and from access by Netlist’s in-house counsel and employees.
Section 4.[***]
Section 5.[***]
Section 6.RESERVATION OF PRIVILEGES; NO WAIVER
All Samsung Documents remain subject to all applicable privileges, protections, and immunities, including the attorney-client privilege, the work-product doctrine, and any other privilege or protection available under applicable law, Samsung does not waive, and shall not be deemed to have waived, any such privilege, protection, or immunity by reason of any production made hereunder, and no such production shall constitute a waiver, in whole or in part, in this or any other proceeding. Any inadvertent production of privileged or protected documents, materials, or information shall not operate as a waiver, and Samsung shall be entitled to the return, sequestration, or destruction of any such items upon request. Netlist does not waive, and shall not be deemed to have waived, any discovery legally available to it.
Section 7.[***]
Section 8.[***]
Section 9.TERM AND TERMINATION
9.1This Agreement shall commence on the Effective Date and shall continue for a period of five (5) years (“Term”).
2
9.2Sections 3, 4, 5, 6, 7, 8, 10 and 12 shall survive any termination or expiration of this Agreement.
Section 10.CONFIDENTIALITY
10.1The existence and terms of this Agreement, and the contents and existence of the Parties’ related discussions (including any related communications, negotiations, deliberations, proposals, and drafts) are confidential and shall not be disclosed by a Party without the other Party’s consent, except to any governmental body having jurisdiction and specifically requiring such disclosure, including the ITC; as may be required under applicable laws or regulations; to a Party’s advisors, subject to confidentiality obligations; and if disclosure is demanded in litigation or an investigation, subject to protective order that such disclosure shall be limited to “Attorneys’ Eyes Only.”
10.2All information provided by a Party to the other Party in connection with this Agreement, excluding Samsung Documents, shall constitute “Confidential Information” and shall be kept strictly confidential. Each Party shall protect and safeguard the other Party’s Confidential Information against unauthorized use or disclosure using no less than reasonable care. [***]. Neither Party shall make any public statements regarding this Agreement without the prior written consent of the other Party.
Section 11.NOTICES
Except for Section 2,3, all notices, consents, approvals, requests, and other communications under this Agreement (each, a “Notice”) must be in writing and delivered personally or by recognized overnight courier, and will be deemed given: (a) when delivered personally, upon delivery; or (b) when sent by a recognized overnight courier, upon written confirmation of delivery or receipt. Notices must be sent to the addresses set forth below (or to such other addresses as a Party may designate by Notice in accordance with this Section).
If to Netlist:
Name: Richard Kim
Title: Vice President of IP Strategy
Address: 111 Academy, Irvine, CA 92617
Email: [***]
Phone: [***]
If to Samsung:
Name: Inseong Na
Title: Head of Licensing Group
Address: 1-1, Samsungjeonja-ro,
Hwaseong-si, Gyeonggi-do, 18448 Korea
Email: [***]
Phone: [***]
3
Section 12.GENERAL PROVISIONS
12.1Neither Party may assign, delegate, or transfer this Agreement or any of its respective rights or obligations herein, by operation of law or otherwise, to any third party without the prior written consent of the other Party. Any assignment in violation of this Section shall be void and of no effect.
12.2Except as set forth in Section 8, each Party shall bear its own expenses, costs, and fees in connection with the transactions contemplated hereby, including the preparation, execution, and delivery of this Agreement, whether or not the transactions contemplated herein are consummated. If the negotiations do not result in the execution of this Agreement, neither Party shall be liable to the other for any claims, expenses or other obligations relating to the discontinuance of negotiations or the failure to enter into this Agreement or the transactions contemplated herein.
12.3This Agreement is governed by and is to be construed in accordance with the laws of [***] without regard to its conflict of laws provisions and as if entirely performed therein. [***].
12.4[***]
12.5This Agreement constitutes the entire understanding between the Parties and supersedes and cancels all prior agreements, express or implied, written or oral, with respect to the subject matter hereof. For the avoidance of doubt, no right or obligation in this Agreement is conditioned upon the performance of any purported obligation in any oral or written agreement other than this Agreement. This Agreement may be modified, but only by a written agreement executed in the same manner as this Agreement.
12.6This Agreement may be executed in duplicate, each of which will be deemed an original, but both of which will constitute one and the same agreement.
[Signature page follows]
4
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.
SAMSUNG ELECTRONICS CO., LTD. | | NETLIST, INC. | ||
By: | /s/ Wonjoo Suh | | By: | /s/ Richard Kim |
Name: | Wonjoo Suh | | Name: | Richard Kim |
Title: | Corporate EVP, Head of IP Team | | Title: | Vice President of IP Strategy |
Date: | August 4, 2026 | | Date: | August 4, 2026 |
5
Exhibit 10.7
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
SECURITIES PURCHASE AGREEMENT
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of July 31, 2026, by and between Netlist, Inc., a Delaware corporation (the “Company”), and Samsung Semiconductor, Inc., a California corporation (the “Investor”).
WHEREAS, the Company and the Investor are entering into a supply agreement of even date herewith (the “Supply Agreement”);
WHEREAS, in connection with the Supply Agreement, the Company and the Investor are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act;
WHEREAS, the Company desires to sell to the Investor, and the Investor desires to purchase from the Company, upon the terms and subject to the conditions stated in this Agreement, shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”); and
NOW THEREFORE, in consideration of the mutual agreements, representations, warranties and covenants herein contained, the Company and the Investor agree as follows:
1.Definitions
As used in this Agreement, the following terms shall have the following respective meanings:
“Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person.
“Aggregate Purchase Amount” has the meaning set forth in Section 2.2.
“Agreement” has the meaning set forth in the recitals.
“Board of Directors” means the board of directors of the Company.
“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions [***] are authorized or required by law or other governmental action to close.
“Bylaws” means the Second Amended and Restated Bylaws of the Company, as currently in effect.
“Certificate of Incorporation” means the Restated Certificate of Incorporation of the Company, as currently in effect.
“Closing” has the meaning set forth in Section 2.2.
“Closing Date” has the meaning set forth in Section 2.2.
“Common Stock” has the meaning set forth in the recitals.
“Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Company” has the meaning set forth in the recitals.
“DGCL” has the meaning set forth in Section 8.3.
“Disclosure Document” has the meaning set forth in Section 5.3.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated thereunder.
“GAAP” has the meaning set forth in Section 3.8.
“Investor” has the meaning set forth in the recitals.
“Liens” means a lien, charge, pledge, security interest or encumbrance.
“Lock-Up and Release Agreement” has the meaning set forth in Section 6.2(f).
“Material Adverse Effect” means any change, event, circumstance, development, condition, occurrence or effect that, individually or in the aggregate, (a) was, is, or would reasonably be expected to be, materially adverse to the business, financial condition, properties, assets, liabilities, stockholders’ equity or results of operations of the Company and its subsidiaries, taken as a whole, or (b) materially delays or materially impairs the ability of the Company to comply, or prevents the Company from complying, with its obligations under this Agreement, the other Transaction Agreements, or with respect to the Closing, or would reasonably be expected to do so.
“Person” means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture or any other entity or organization.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.
[***]
2
“Rule 144” means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.
“SEC” means the U.S. Securities and Exchange Commission.
“SEC Reports” means (a) the Company’s most recently filed Annual Report on Form 10-K; (b) all Quarterly Reports on Form 10-Q or Current Reports on Form 8-K filed or furnished (as applicable) by the Company following the end of the most recent fiscal year for which an Annual Report on Form 10-K has been filed and prior to the execution of this Agreement; and (c) any other reports or statement filed by the Company pursuant to the Exchange Act, together in each case with any documents incorporated by reference therein or exhibits thereto.
“Securities Act” means the U.S. Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder.
“Share Price” means $0.10.
“Shares” has the meaning set forth in the recitals.
“Short Sales” include, without limitation, (a) all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and (b) sales and other transactions through non-U.S. broker dealers or non-U.S. regulated brokers (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).
“Subsidiary” means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.
“Supply Agreement” has the meaning set forth in the recitals.
“Tax” or “Taxes” means any and all federal, state, local, foreign and other taxes, levies, fees, imposts, duties and charges of whatever kind (including any interest, penalties or additions to the tax imposed in connection therewith or with respect thereto), whether or not imposed on the Company or its subsidiaries (if any) including, without limitation, taxes imposed on, or measured by, income, franchise, profits or gross receipts, and also ad valorem, value added, sales, use, service, real or personal property, capital stock, license, payroll, withholding, employment, social security, workers’ compensation, unemployment compensation, utility, severance, production, excise, stamp, occupation, premium, windfall profits, transfer and gains taxes and customs duties.
“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question, together with any successor thereto: the NYSE American, The New York Stock Exchange, The Nasdaq Global Market, The Nasdaq Global Select Market, The Nasdaq Capital Market, OTCQB or OTCQX.
3
“Transaction Agreements” means this Agreement and the Lock-Up and Release Agreement.
“Transfer Agent” means, with respect to the Common Stock, [***] or such other financial institution that provides transfer agent services as the Company may engage from time to time.
2.Purchase and Sale of Shares.
2.1Purchase and Sale. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Investor agrees to purchase, the number of Shares, for the purchase price, set forth opposite the Investor’s name on Exhibit A. The purchase price per Share is equal to the Share Price.
2.2Closing. Subject to the satisfaction or waiver of the conditions set forth in Section 6 of this Agreement, the closing of the purchase and sale of the Shares (the “Closing” and the date on which the Closing occurs, the “Closing Date”) shall occur [***] in no event later than five (5) Business Days after the date of this Agreement. At the Closing, the Shares shall be issued and registered in the name of the Investor, or in such nominee name(s) as designated by such Investor, representing the number of Shares to be purchased by the Investor at such Closing as set forth in Exhibit A, in each case against payment to the Company of the purchase price therefor (the “Aggregate Purchase Amount”) in full, [***].
3.Representations and Warranties of the Company. Except as set forth in the SEC Reports (which shall be deemed to qualify any representation set forth herein), the Company hereby represents and warrants to the Investor that the statements contained in this Section 3 are true and correct as of the date of this Agreement and as of the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date).
3.1Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. [***].
3.2Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. [***].
3.3 Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Agreements and otherwise to carry out its obligations hereunder and thereunder. [***].
3.4 No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Agreements to which it is a party, the issuance and sale of the Shares and the consummation by it of the transactions contemplated hereby and thereby
4
do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, [***].
3.5[***]
3.6Issuance of the Shares. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Agreements, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens. [***].
3.7[***]
3.8SEC Reports; Financial Statements. The Company has filed all SEC Reports on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
3.9Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
4.Representations and Warranties of The Investor. The Investor represents and warrants to the Company that the statements contained in this Section 4 are true and correct as of the date of this Agreement and the Closing Date:
5
4.1Organization. The Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has the requisite power and authority to own, lease and operate its properties and to carry on its business as now conducted.
4.2Authorization. The Investor has all requisite corporate or similar power and authority to enter into this Agreement and the other Transaction Agreements to which it will be a party and to carry out and perform its obligations hereunder and thereunder. [***].
4.3No Conflicts. The execution, delivery and performance of the Transaction Agreements by the Investor, the purchase of the Shares in accordance with the terms hereof and the consummation by the Investor of the other transactions contemplated hereby will not conflict with or result in any violation of, breach or default by such Investor (with or without notice or lapse of time, or both) under, conflict with, or give rise to a right of termination, cancellation or acceleration of any obligation, a change of control right or to a loss of a material benefit under (i) any provision of the organizational documents of the Investor, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable or (ii) any judgment, order, ruling, statute, law, ordinance, rule or regulations, applicable to such Investor or its respective properties or assets, except, in the case of clause (ii), as would not, individually or in the aggregate, be reasonably expected to materially delay or hinder the ability of the Investor to perform its obligations under the Transaction Agreements.
4.4[***]
4.5[***]
4.6Investment Representations and Warranties. The Investor hereby represents and warrants that it as of the date of this Agreement is, a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an “accredited investor” as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act. The Investor further represents and warrants that (i) it is capable of evaluating the merits and risk of such investment, and (ii) that it has not been organized for the purpose of acquiring the Shares and is an “institutional account” as defined by FINRA Rule 4512(c). The Investor understands and agrees that the offering and sale of the Shares has not been registered under the Securities Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed herein.
4.7Intent. The Investor is purchasing the Shares solely for the Investor’s own account and not for the account of others, and not with a view to the resale or distribution of any part thereof in violation of the Securities Act, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the Investor’s right at all times to sell or otherwise dispose of all or any part of such Shares in compliance with applicable federal and state securities laws. [***].
4.8Investment Experience; Ability to Protect Its Own Interests and Bear Economic Risks. The Investor acknowledges that it can bear the economic risk and complete loss
6
of its investment in the Shares and has knowledge and experience in finance, securities, taxation, investments and other business matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby, and the Investor has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Investor has considered necessary to make an informed investment decision. The Investor acknowledges that the Investor (i) is a sophisticated investor, experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent judgment in evaluating its participation in the purchase of the Shares. The Investor acknowledges that the Investor is aware that there are substantial risks incident to the purchase and ownership of the Shares, including those set forth in the Company’s filings with the SEC.
4.9Independent Investment Decision. The Investor understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of the Company to the Investor in connection with the purchase of the Shares constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and investment advisors as it, in such Investor’s sole discretion, has deemed necessary or appropriate in connection with its purchase of the Shares.
4.10Shares Not Registered; [***]. The Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act, and the Investor understands that the Shares have not been registered under the Securities Act, [***].
4.11No General Solicitation. The Investor acknowledges and agrees that the Investor is purchasing the Shares directly from the Company. The Investor became aware of this offering of the Shares directly from the Company as a result of a pre-existing, substantive relationship with the Company. The Shares were offered to the Investor solely by direct contact between Investor and the Company. The Investor did not become aware of this offering of the Shares, nor were the Shares offered to the Investor, by any other means, and the Company did not act as investment advisor, broker or dealer to the Investor. The Investor is not purchasing the Shares as a result of any general or public solicitation or general advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.
4.12Access to Information. In making its decision to purchase the Shares, such Investor has relied solely upon independent investigation made by such Investor, upon the SEC Reports and upon the representations, warranties and covenants set forth herein. Such Investor acknowledges and agrees that such Investor and the Investor’s professional advisor(s), if any, have had the opportunity to ask such questions, receive such answers and obtain such information from the Company regarding the Company, its business and the terms and conditions of the offering of the Shares as the Investor and the Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares and that the Investor has independently made its own analysis and decision to invest in the Company. Neither such inquiries nor any other due diligence investigation conducted by the Investor shall modify, limit or otherwise affect the
7
Investor’s right to rely on the Company’s representations and warranties contained in this Agreement.
4.13[***]
5.Covenants.
5.1Defense Production Act. Notwithstanding anything to the contrary in this Agreement, neither Investor’s acquisition or ownership of any securities of the Company, Investor’s status as an investor or securityholder of the Company, nor any right granted to Investor under this Agreement or any other agreement or instrument governing Investor’s investment in the Company shall afford Investor, in its capacity as an investor or securityholder, any of the following access, rights or involvement with respect to the Company in each case within the meaning of Section 721 of the Defense Production Act, as amended, including its implementing regulations: (a) “control” of the Company, including the power to determine, direct or decide any important matters affecting the Company; (b) membership or observer rights on the Board of Directors or equivalent body of the Company, or the right to nominate an individual to a position on the Board of Directors or equivalent body of the Company; (c) access to any “material nonpublic technical information” in the possession of the Company (provided, however, that such prohibited information shall not include financial information regarding the performance of the Company, and provided further that Investor may confer with the Company about such financial information); and (d) any “involvement” (other than through voting of shares) in “substantive decision making” of the Company regarding (i) the use, development, acquisition, safekeeping, or release of “sensitive personal data” of U.S. citizens maintained or collected by the Company, (ii) the use, development, acquisition, or release of “critical technologies,” or (iii) the management, operation, manufacture, or supply of “covered investment critical infrastructure.”
5.2Further Assurances. Each party agrees to cooperate with each other and their respective officers, employees, attorneys, accountants and other agents, and, generally, do such other reasonable acts and things in good faith as may be necessary to effectuate the intents and purposes of this Agreement, subject to the terms and conditions of this Agreement and compliance with applicable law, including taking reasonable action to facilitate the filing of any document or the taking of reasonable action to assist the other parties hereto in complying with the terms of this Agreement. The Investor acknowledges that the Company will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Agreement. Prior to the Closing, the Investor agrees to promptly notify the Company if any of the acknowledgments, understandings, agreements, representations and warranties set forth in Section 4 of this Agreement are no longer accurate.
5.3[***]
5.4[***]
5.5[***]
(a)[***]
(b)[***]
8
5.6Withholding Taxes. The Investor agrees to furnish the Company with any information, representations and forms as shall reasonably be requested by the Company from time to time to assist the Company in complying with any applicable tax law (including any withholding obligations).
5.7No Conflicting Agreements. The Company will not take any action, enter into any agreement or make any commitment that would conflict or interfere in any material respect with the Company’s obligations to the Investor under the Transaction Agreements.
5.8Rule 144 Compliance. At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Shares may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, the Company shall comply with the current public information requirement under Rule 144(c).
5.9Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed or quoted, and concurrently with the Closing and to the extent required by the Trading Market, the Company shall apply to list or quote all of the Shares on such Trading Market and promptly secure the listing of all of the Shares on such Trading Market. Conditions of Closing.
6.[***]
6.1[***]
(a)[***]
(b)[***]
(c)[***]
(d)[***]
(e)[***]
(f)[***]
(g)[***]
(h)[***]
6.2[***]
(a)[***]
(b)[***]
(c)[***]
9
(d)Payment. Except as may be agreed to among the Company and the Investor in accordance with Section 2.2, the Company shall have received payment, [***], in the full amount of the purchase price for the number of Shares being purchased by the Investor at the Closing as set forth in Exhibit A.
(e)Supply Agreement. The [Investor] shall have executed and delivered the Supply Agreement.
(f)Lock-Up and Release Agreement. The Investor shall have executed and delivered a Lock-Up Agreement to the Company in the form attached as Exhibit B (the “Lock-Up and Release Agreement”).
7.Termination.
7.1Termination. The obligations of the Company, on the one hand, and the Investor, on the other hand, to effect the Closing shall terminate as follows:
(i)Upon the mutual written consent of the Company and the Investor prior to the Closing;
(ii)[***]
(iii)[***]
[***]
7.2Notice. Nothing in this Section 7 shall be deemed to release any party from any liability for any breach by such party of the other terms and provisions of the Transaction Agreements or to impair the right of any party to compel specific performance by any other party of its other obligations under the Transaction Agreements.
8.Miscellaneous Provisions.
8.1Public Statements or Releases. Except as set forth in Section 5.3, neither the Company nor the Investor shall make any public announcement with respect to the existence or terms of this Agreement or the transactions provided for herein without the prior consent of the other party (which consent shall not be unreasonably withheld). Notwithstanding the foregoing, and subject to compliance with Section 5.3, nothing in this Section 8.1 shall prevent any party from making any public announcement it considers necessary in order to satisfy its obligations under the law, including applicable securities laws, or under the rules of any national securities exchange or securities market; provided that the Company shall, for any press release relating to, referring to or discussing Investor’s investment hereunder, and to the extent allowed by law, afford the Investor with reasonable opportunity to review and comment on such disclosures for consideration by the Company. Nothing in this Agreement shall limit the Company’s sole discretion concerning what constitutes material information to be included in disclosures required by law; provided that, with respect to the first press release announcing the transactions hereunder, the Company will use its reasonable efforts to ensure that the interests of both parties are aligned.
10
8.2Notices. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a) when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business Day, (c) three (3) days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt:
(a)If to the Company, addressed as follows:
Netlist, Inc.
111 Academy, Suite 100
Irvine, California 92617 USA
Attention: Gail Sasaki
Email: [***]
with a copy (which shall not constitute notice):
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
3580 Carmel Mountain Road
San Diego, CA 92130
Attention: Scott Stanton
Email: [***]
(b)If to the Investor, addressed as follows:
Samsung Semiconductor, Inc.
3655 N. 1st Street
San Jose, California 95134 USA
Attention: SVP David (Dede) Goldschmidt
Email: [***]
with a copy (which shall not constitute notice):
Samsung Semiconducter, Inc.
3655 N. 1st Street
San Jose, California 95134 USA
Attention: Cindy Dole
Email: [***]
Any Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.
8.3Consent to Electronic Notice. The Investor consents to the delivery of any stockholder notice pursuant to Section 232 of the Delaware General Corporation Law, as amended or superseded from time to time (the “DGCL”), [***], as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or
11
undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.
8.4Severability. If any part or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto.
8.5Governing Law; Submission to Jurisdiction; Venue; Waiver of Trial by Jury.
(a)This Agreement shall be governed by, and construed in accordance with, the laws of [***] without regard to choice of laws or conflicts of laws provisions thereof that would require the application of the laws of any other jurisdiction, except to the extent that mandatory principles of Delaware law may apply.
(b)The Company and the Investor hereby irrevocably and unconditionally:
(i)[***]
(ii)consents that any such action or proceeding may be brought in such courts, and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same to the extent permitted by applicable law;
(iii)agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address set forth in Section 8.2 or at such other address of which the other party shall have been notified pursuant thereto;
(iv)agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if jurisdiction in the courts referenced in the foregoing clause (i) are not available despite the intentions of the parties hereto;
(v)agrees that final judgment in any such suit, action or proceeding brought in such a court may be enforced in the courts of any jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party in the manner specified herein or as otherwise permitted by law;
(vi)agrees that to the extent that such party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process with respect to itself or its property, such party hereby irrevocably waives such immunity in respect of its obligations under this Agreement, to the extent permitted by law; and
12
(vii)irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation to this Agreement.
8.6Waiver. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.
8.7[***]
8.8Assignment. None of the parties may assign its rights or obligations under this Agreement or designate another person (i) to perform all or part of its obligations under this Agreement or (ii) to have all or part of its rights and benefits under this Agreement, in each case without the prior written consent of (x) the Company, in the case of the Investor, and (y) the Investor, in the case of the Company.
8.9Confidential Information.
(a)[***]
(b)[***]
8.10Third Parties. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties to this Agreement any rights, remedies, claims, benefits, obligations or liabilities under or by reason of this Agreement, and no Person that is not a party to this Agreement (including, without limitation, any partner, member, shareholder, director, officer, employee or other beneficial owner of any party to this Agreement, in its own capacity as such or in bringing a derivative action on behalf of a party to this Agreement) shall have any standing as a third party beneficiary with respect to this Agreement or the transactions contemplated hereby.
8.11Headings. The titles, subtitles and headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.
8.12Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile or pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.
8.13Entire Agreement; Amendments. This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and thereto) constitute the entire agreement between the parties hereto respecting the subject matter of this Agreement and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter of this Agreement, whether written or oral. For the avoidance of doubt, no right or obligation in this Agreement is conditioned upon the performance of any purported obligation in any oral or written agreement other than this Agreement and other
13
Transaction Agreements (including all schedules and exhibits hereto and thereto). [***]. No amendment, modification, alteration, or change in any of the terms of this Agreement shall be valid or binding upon the parties hereto unless made in writing and duly executed by the Company and the Investor. The Company, on the one hand, and the Investor, on the other hand, may by an instrument signed in writing by such parties waive the performance, compliance or satisfaction by the Investor or the Company, respectively, with any term or provision of this Agreement or any condition hereto to be performed, complied with or satisfied by the Investor or the Company, respectively.
8.14Survival. The covenants, representations and warranties made by each party hereto contained in this Agreement shall survive the Closing and the delivery of the Shares in accordance with their respective terms.
8.15Contract Interpretation. This Agreement is the joint product of the Investor and the Company and each provision of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
8.16Arm’s Length Negotiations. For the avoidance of doubt, the parties acknowledge and confirm that the terms and conditions of the Shares were determined as a result of arm’s-length negotiations.
[Remainder of Page Intentionally Left Blank.]
14
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
| COMPANY: | |
| | |
| NETLIST, INC. | |
| | |
| By: | /s/ Gail Sasaki |
| Name: | Gail Sasaki |
| Title: | Chief Financial Officer |
| Date: | August 3, 2026 |
15
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
| INVESTOR: | |
| | |
| SAMSUNG SEMICONDUCTOR, INC. | |
| | |
| By: | /s/ Sang-jin Oh |
| Name: | Sang-jin Oh |
| Title: | Chief Financial Officer |
| Date: | August 4, 2026 |
16
EXHIBIT A
INVESTOR
Investor Name | | Shares | | | Purchase Price |
| | | | | |
Samsung Semiconductor, Inc. | | 10,000,000 | | $ | 1,000,000.00 |
A-1
EXHIBIT B
FORM OF LOCK-UP AND RELEASE AGREEMENT
B-1
Exhibit 10.8
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) is the type that the registrant treats as private or confidential.
EXHIBIT B
LOCK-UP AND RELEASE AGREEMENT
July 31, 2026
Re: | Securities Purchase Agreement, dated as of July 31, 2026 (the “Purchase Agreement”), between Netlist, Inc. (the “Company”) and Samsung Semiconductor, Inc. (the “Investor”) |
Ladies and Gentlemen:
Defined terms not otherwise defined in this letter agreement (the “Letter Agreement”) shall have the meanings set forth in the Purchase Agreement. [***].
Notwithstanding the foregoing restrictions, the Lock-Up Shares shall be released from the restrictions set forth in this Letter Agreement in accordance with the following schedule (each such date, a “Release Date”): (i) twenty percent (20%) of the Lock-Up Shares (rounded down to the nearest whole share) shall be released on the first (1st) anniversary of the Closing Date; (ii) an additional twenty percent (20%) of the Lock-Up Shares (rounded down to the nearest whole share) shall be released on the second (2nd) anniversary of the Closing Date; (iii) an additional twenty percent (20%) of the Lock-Up Shares (rounded down to the nearest whole share) shall be released on the third (3rd) anniversary of the Closing Date; (iv) an additional twenty percent (20%) of the Lock-Up Shares (rounded down to the nearest whole share) shall be released on the fourth (4th) anniversary of the Closing Date; and (v) all remaining Lock-Up Shares shall be released on the fifth (5th) anniversary of the Closing Date. [***].
[***]
For the avoidance of doubt, [***]. This Letter Agreement may not be amended or otherwise modified in any respect without the written consent of each of the Company and the undersigned. This Letter Agreement shall be governed by, and construed in accordance with, the laws of [***] without regard to choice of laws or conflicts of laws provisions thereof that would require the application of the laws of any other jurisdiction, except to the extent that mandatory principles of [***] law may apply. The undersigned hereby irrevocably submits to the general jurisdiction of [***], and hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that (i) it is not personally subject to the jurisdiction of such court, (ii) the suit, action or proceeding is brought in an inconvenient forum, or (iii) the venue of the suit, action or proceeding is improper. [***].
[***]
*** SIGNATURE PAGE FOLLOWS***
IN WITNESS WHEREOF, the undersigned has caused this Letter Agreement to be duly executed by its authorized signatory as of the date first indicated above.
| INVESTOR: | |
| | |
| SAMSUNG SEMICONDUCTOR, INC. | |
| | |
| By: | /s/ Sang-jin Oh |
| Name: | Sang-jin Oh |
| Title: | Chief Financial Officer |
| Date: | August 4, 2026 |
Exhibit 10.9
NETLIST, INC.
111 Academy Drive, Suite 100, Irvine, California 92617
November 6, 2026
PERSONAL AND CONFIDENTIAL
Mr. Chun K. Hong
Re:Retention Bonus Letter
Dear Mr. Hong:
You have made extraordinary contributions to the multiyear intellectual property monetization strategy of Netlist, Inc. (the “Company”), including the negotiation and execution of significant patent license agreements. The Board of Directors of the Company (the “Board”), advised by its independent compensation consultant, has determined that the historical cash compensation of the Company’s senior executives has been conservative relative to its peer group, and the Board wishes to promote your continued retention as President and Chief Executive Officer. Accordingly, on November 6, 2026 (the “Effective Date”), the Board approved the one-time cash retention bonus described in this letter (this “Letter”), subject to the terms and repayment conditions set forth below. The Retention Bonus recognizes extraordinary contributions and creates no right to, or precedent for, future compensation.
1. | Retention Bonus; Payment Schedule. You are eligible to receive a cash retention bonus in the aggregate amount of $25,000,000 (the “Retention Bonus”), payable in five installments (each, an “Installment”) on the scheduled dates set forth below (each, a “Payment Date”). A Payment Date is the scheduled date on which an Installment may be earned; actual payment timing, acceleration and forfeiture are governed by Sections 2 through 5. |
Installment | Scheduled Payment Date | Amount |
|---|---|---|
Initial Installment (40%) | Later of the Effective Date and the date you sign this Letter | $10,000,000 |
Second Installment (15%) | February 15, 2027 | $3,750,000 |
Third Installment (15%) | May 15, 2027 | $3,750,000 |
Fourth Installment (15%) | August 15, 2027 | $3,750,000 |
Fifth Installment (15%) | November 15, 2027 | $3,750,000 |
Total | | $25,000,000 |
2. | Conditions to Earning; Payment Timing. An Installment is earned only if (a) you remain continuously employed by the Company through its Payment Date and (b) you have not materially breached your Employment Agreement with the Company dated September 5, |
Page 1
2006 (the “Employment Agreement”) or your Proprietary Information and Invention Assignment Agreement with the Company or any other written confidentiality, proprietary information, invention assignment, non-solicitation or similar agreement between you and the Company (each, a “Restrictive Covenant Agreement”). Each earned Installment will be paid no later than the Company’s next regular payroll date after its Payment Date, and in any event no later than March 15 of the following calendar year. Clause (b) applies to accelerated Installments as well as scheduled Installments.
3. | Effect of Termination of Employment. |
(a) | General Forfeiture. Except as provided in Section 3(b) and Section 5, upon termination of your employment for any reason, including your death or a termination due to disability (as determined in accordance with Section 4.6 of the Employment Agreement), all Installments not earned under Section 2 on or before the termination date are forfeited. No Installment is accelerated upon your death or disability. An Installment earned on or before termination but not yet paid remains payable on its normal schedule under Section 2, subject to Section 4(b). |
(b) | Termination without Cause or Resignation for Good Reason. If the Company terminates your employment without Cause or you resign for Good Reason (each as defined in Sections 4.2 and 4.3(a), respectively, of the Employment Agreement), all unpaid Installments not already earned under Section 2 will be paid to you in a lump sum within 60 days after your termination date, subject to Section 2(b), Section 4(b), and a general release of claims in favor of the Company and its affiliates, in a form provided by the Company (a “Release”), becoming effective and irrevocable within that 60-day period. Any Installment that fails these conditions is forfeited. If the 60-day period spans two calendar years, payment will be made in the second calendar year. |
4. | Early Departure Repayment. |
(a) | Voluntary Resignation. If you resign without Good Reason during the three-year period beginning on the Effective Date (the “Retention Period”), you must repay the Retained Amount multiplied by a fraction equal to the number of full calendar months remaining in the Retention Period after your termination date divided by 36. “Retained Amount” means the gross amount of Installments paid to you. |
(b) | Termination for Cause; After-Discovered Cause. Subject to Section 5, if your employment is terminated for Cause during the Retention Period, you must repay 100% of the Retained Amount. If, after any termination of your employment and during the Retention Period, the Board determines, subject to all notice, hearing, appeal and other procedural requirements applicable to a termination for Cause under Section 4.2 of the Employment Agreement, that Cause existed at termination, your termination will be deemed to have been for Cause as of the original termination date for all purposes of Sections 2 through 6. In that event, all then-unpaid accelerated Installments are forfeited, and you must repay all Installments paid (including accelerated Installments), less any amounts already recovered and retained by the Company under Section 4(a). |
Page 2
(c) | No Repayment upon Other Terminations. Subject to Section 4(b), no repayment is required under this Section 4 upon a termination of your employment by the Company without Cause, by you for Good Reason, or due to your death or disability. Any amount repayable under this Section 4 is an “Early Departure Repayment.” |
5. | Change in Control. Upon consummation, during your employment, of a “Change in Control” (which, for purposes of this Letter, has the meaning given to “Change of Control” in Section 4.3(a) of the Employment Agreement), all unpaid Installments will be paid to you in a lump sum within 30 days, subject to Section 2(b). Section 4 will then cease to apply, except that any Early Departure Repayment determined before the Change in Control remains due. This Section 5 does not limit recovery under Section 7. |
6. | Repayment Terms. |
(a) | Repayment Obligation. Each Early Departure Repayment is your unconditional obligation, payable in cash in a lump sum within 30 days after the Board’s written demand, on a gross (pre-tax) basis, except that the Board may permit repayment net of taxes withheld if made in the calendar year in which the related Installment was paid. Installments are paid subject to the repayment conditions of this Letter and are not advances. Your repayment obligations survive termination of your employment and of this Letter and bind your estate. |
(b) | Remedies. The Company may recover any amount owed by any lawful means, including arbitration under Section 11(e), and you must reimburse the Company’s reasonable collection costs, including attorneys’ fees, to the extent recovery is permitted by applicable law; this obligation survives termination of your employment and of this Letter. As a cumulative, non-exclusive remedy, the Company may offset amounts owed against amounts payable to you, but only as permitted by Section 409A of the Internal Revenue Code of 1986, as amended (the “Code” and such section, “Section 409A”), and applicable law. The Company will not extend the time for, or accept installment payments of, any repayment. |
7. | Clawback Policy. The Retention Bonus is subject to any Company recoupment or clawback policy in effect on or adopted after the Effective Date, including any policy adopted under Section 10D of the Securities Exchange Act of 1934, as amended, Rule 10D-1 thereunder or the listing standards of any national securities exchange on which the Company’s securities are listed (including in connection with any such listing), and to Section 304 of the Sarbanes-Oxley Act of 2002. You consent to any amendment of this Letter needed to comply with any such policy. Recovery under any such policy supplements, and does not duplicate, recovery under this Letter. |
8. | Tax Matters. |
(a) | Withholding; Tax Consequences. All payments are subject to applicable tax withholding, and the Company makes no representation regarding the tax treatment of the Retention Bonus or any repayment, and you bear all tax consequences of any repayment, without gross-up. |
Page 3
(b) | Section 409A. All payments are intended to be exempt from Section 409A as short-term deferrals and will be interpreted accordingly. Each Installment is a separate payment. The Company has no liability under Section 409A. |
(c) | Other Benefits. The Retention Bonus is not compensation for purposes of any benefit plan or severance calculation and does not reduce any severance or affect any equity award. |
9. | Relationship to the Employment Agreement. This Letter is separate from the Employment Agreement. This Letter is the entire agreement regarding the Retention Bonus and, solely as to the Retention Bonus, controls notwithstanding any inconsistent provision of the Employment Agreement, including the exclusive-remedy provision of Section 4.1 and the integration and modification provisions of Section 5.4 thereof, and this Letter is a writing signed by you and the Company for purposes of any such provision. Otherwise, the Employment Agreement remains in full force and effect. |
10. | Board Determinations; Amendment. The Board has authority to interpret this Letter and to make all determinations under it, including any determination of Cause or any repayment amount, which may not be delegated. Board determinations are final and binding, reviewable only as arbitrary and capricious. You will recuse yourself from all Board deliberations and actions under this Letter. This Letter may be amended only by a writing signed by you and the Company, except that the Company may amend it without your consent as needed to comply with applicable law, Section 409A or any policy described in Section 7. |
11. | General Provisions. |
(a) | No Right to Employment. This Letter confers no right to continued employment and does not limit the Company’s right to terminate your employment, subject to the Employment Agreement. |
(b) | Unfunded Obligation. The Retention Bonus is unfunded, and you are a general unsecured creditor of the Company as to any amount payable under this Letter. |
(c) | Non-Assignment; Successors. Your rights under this Letter may not be assigned, transferred, pledged or encumbered, except by will or the laws of descent and distribution. This Letter binds the Company and its successors. |
(d) | Governing Law. This Letter is governed by California law, without regard to conflict of laws principles. |
(e) | Disputes. Any dispute under this Letter will be resolved by final and binding arbitration in Orange County, California, in accordance with the Agreement to Arbitrate attached as Exhibit A to the Employment Agreement or, if it does not apply, under JAMS rules. |
(f) | Miscellaneous. If any provision of this Letter is held invalid or unenforceable, the remaining provisions remain effective. |
12. | Review; Advice of Counsel. You acknowledge that you have read this Letter, including the repayment provisions of Sections 4 and 6 and the clawback provisions of Section 7, to |
Page 4
which you expressly consent; that you were advised to consult an attorney of your choice about this Letter and had at least five business days to do so before signing; and that the Company has made no representation regarding the tax consequences of the Retention Bonus or any repayment.
13. | Acceptance. Please sign and return this Letter confirming your acceptance of its terms. This Letter may be signed in counterparts and electronically. |
Sincerely,
NETLIST, INC. | | ||
| | ||
By: | /s/ Blake Welcher | | |
Name: Blake Welcher | | ||
Title: Authorized Signatory | | ||
ACCEPTED AND AGREED: | | |
| | |
/s/ Chun K. Hong | | |
Chun K. Hong | | |
Date: November 6, 2026 | | |
Page 5
Exhibit 10.10
NETLIST, INC.
111 Academy Drive, Suite 100, Irvine, California 92617
November 6, 2026
PERSONAL AND CONFIDENTIAL
Ms. Gail Sasaki
Re:Retention Bonus Letter
Dear Ms. Sasaki:
You have made extraordinary contributions to the multiyear intellectual property monetization strategy of Netlist, Inc. (the “Company”), including the negotiation and execution of significant patent license agreements. The Board of Directors of the Company (the “Board”), advised by its independent compensation consultant, has determined that the historical cash compensation of the Company’s senior executives has been conservative relative to its peer group, and the Board wishes to promote your continued retention as Chief Financial Officer. Accordingly, on November 6, 2026 (the “Effective Date”), the Board approved the one-time cash retention bonus described in this letter (this “Letter”), subject to the terms and repayment conditions set forth below. The Retention Bonus recognizes extraordinary contributions and creates no right to, or precedent for, future compensation.
1. | Retention Bonus; Payment. You will receive a one-time cash retention bonus in the amount of $4,000,000 (the “Retention Bonus”), payable in a single lump sum no later than the Company’s next regular payroll date following the date you sign this Letter. The Retention Bonus is paid in advance, subject to the repayment conditions set forth in Sections 3 and 5. |
2. | Definitions. The following terms have the meanings set forth below for purposes of this Letter: |
(a) | Cause. “Cause” means a reasonable determination by the Board, acting in good faith based upon actual knowledge at the time, that you have (i) materially breached your Proprietary Information and Invention Assignment Agreement with the Company, any other written confidentiality, proprietary information, invention assignment, non-solicitation or similar agreement between you and the Company, or any other material agreement between you and the Company, (ii) committed gross negligence or engaged in serious misconduct in the execution of your assigned duties, (iii) been convicted of a felony or other serious crime involving moral turpitude, (iv) materially refused to perform any lawful duty or responsibility consistent with your position with the Company, or (v) materially breached your fiduciary duty or your duty of loyalty to the Company. Your employment will not be terminated for Cause unless and until you have received written notice of a proposed termination for Cause setting forth the basis therefor and have had an |
Page 1
opportunity to be heard at a meeting with at least a majority of the members of the Board, which opportunity will be deemed given if you receive such notice at least 72 hours in advance of the meeting.
(b) | Change in Control. “Change in Control” means the occurrence of any of the following events: (i) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “Beneficial Owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company or its affiliates or by any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions which the Board does not approve; or (ii) (A) a merger or consolidation of the Company whether or not approved by the Board, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such entity) more than 50% of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by the Company of all or substantially all of the Company’s assets in a transaction requiring shareholder approval; or (iii) a change in the composition of the Board, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who either (A) are directors of the Company as of the Effective Date, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company). |
(c) | Good Reason. “Good Reason” means (i) the assignment to you, without your consent, of duties inconsistent with your position so as to constitute a diminution of status with the Company, including any change in your title or an assignment of you to a position other than Chief Financial Officer of the Company, (ii) a reduction by the Company in your base salary as in effect at any time without your consent, other than a decrease of up to (and including) ten percent (10%) in connection with an adverse change in the business operations or financial condition of the Company, or (iii) a requirement that you relocate (or report on a regular basis) to an office outside of Orange County, California without your consent; provided that a resignation will be for Good Reason only if you give the Company written notice of your resignation stating the event constituting Good Reason and your resignation is effective during the Retention Period. |
Page 2
3. | Early Departure Repayment. |
(a) | Voluntary Resignation. If you resign for any reason other than Good Reason during the two-year period beginning on the Effective Date (the “Retention Period”), you must repay to the Company an amount equal to the Retention Bonus multiplied by a fraction equal to the number of full calendar months remaining in the Retention Period after your termination date divided by 24. |
(b) | Termination for Cause; After-Discovered Cause. Subject to Section 4, if your employment is terminated for Cause during the Retention Period, you must repay 100% of the Retention Bonus. If, after any termination of your employment (other than due to your death or disability) and during the Retention Period, the Board determines, following the notice and opportunity to be heard described in Section 2(a), that Cause existed at termination, your termination will be deemed to have been for Cause as of the original termination date for all purposes of this Letter, and you must repay 100% of the Retention Bonus, less any amounts already recovered and retained by the Company under Section 3(a). |
(c) | No Repayment upon Other Terminations. Subject to Section 3(b), no repayment is required under this Section 3 upon a termination of your employment by the Company without Cause, by you for Good Reason, or due to your death or disability. Any amount repayable under this Section 3 is an “Early Departure Repayment.” |
4. | Change in Control. Upon consummation, during your employment, of a Change in Control, Section 3 will cease to apply, except that any Early Departure Repayment determined before the Change in Control remains due. This Section 4 does not limit recovery under Section 6. |
5. | Repayment Terms. |
(a) | Repayment Obligation. Each Early Departure Repayment is your unconditional obligation, payable in cash in a lump sum within 30 days after the Board’s written demand, on a gross (pre-tax) basis, except that the Board may permit repayment net of taxes withheld if made in the calendar year in which the Retention Bonus was paid. The Retention Bonus is paid subject to the repayment conditions of this Letter and is not an advance of wages. Your repayment obligations survive termination of your employment and of this Letter and bind your estate. |
(b) | Remedies. The Company may recover any amount owed by any lawful means, including arbitration under Section 10(e), and you must reimburse the Company’s reasonable collection costs, including attorneys’ fees, to the extent recovery is permitted by applicable law; this obligation survives termination of your employment and of this Letter. As a cumulative, non-exclusive remedy, the Company may offset amounts owed against amounts payable to you, but only as permitted by Section 409A of the Internal Revenue Code of 1986, as amended (the |
Page 3
“Code” and such section, “Section 409A”), and applicable law. The Company will not extend the time for, or accept installment payments of, any repayment.
6. | Clawback Policy. The Retention Bonus is subject to any Company recoupment or clawback policy in effect on or adopted after the Effective Date, including any policy adopted under Section 10D of the Securities Exchange Act of 1934, as amended, Rule 10D-1 thereunder or the listing standards of any national securities exchange on which the Company’s securities are listed (including in connection with any such listing), and to Section 304 of the Sarbanes-Oxley Act of 2002. You consent to any amendment of this Letter needed to comply with any such policy. Recovery under any such policy supplements, and does not duplicate, recovery under this Letter. |
7. | Tax Matters. |
(a) | Withholding; Tax Consequences. All payments are subject to applicable tax withholding, and the Company makes no representation regarding the tax treatment of the Retention Bonus or any repayment, and you bear all tax consequences of any repayment, without gross-up. |
(b) | Section 409A. All payments are intended to be exempt from Section 409A as short-term deferrals and will be interpreted accordingly. The Company has no liability under Section 409A. |
8. | Entire Agreement. This Letter is the entire agreement between you and the Company regarding the Retention Bonus and supersedes all prior discussions and understandings regarding the Retention Bonus. |
9. | Board Determinations; Amendment. The Board has authority to interpret this Letter and to make all determinations under it, including any determination of Cause, any determination of whether your termination of employment was due to disability, or any repayment amount, which may not be delegated. Board determinations are final and binding, reviewable only as arbitrary and capricious. This Letter may be amended only by a writing signed by you and the Company, except that the Company may amend it without your consent as needed to comply with applicable law, Section 409A or any policy described in Section 6. |
10. | General Provisions. |
(a) | No Right to Employment. This Letter confers no right to continued employment and does not limit the Company’s right to terminate your employment at any time. Your employment remains at will. |
(b) | Unfunded Obligation. The Retention Bonus is unfunded, and you are a general unsecured creditor of the Company as to any amount payable under this Letter. |
(c) | Non-Assignment; Successors. Your rights under this Letter may not be assigned, transferred, pledged or encumbered, except by will or the laws of descent and distribution. This Letter binds the Company and its successors. |
Page 4
(d) | Governing Law. This Letter is governed by California law, without regard to conflict of laws principles. |
(e) | Disputes. Any dispute under this Letter will be resolved by final and binding arbitration in Orange County, California, under the JAMS Employment Arbitration Rules & Procedures then in effect. |
(f) | Miscellaneous. If any provision of this Letter is held invalid or unenforceable, the remaining provisions remain effective. |
11. | Review; Advice of Counsel. You acknowledge that you have read this Letter, including the repayment provisions of Sections 3 and 5 and the clawback provisions of Section 6, to which you expressly consent; that you were advised to consult an attorney of your choice about this Letter before signing; and that the Company has made no representation regarding the tax consequences of the Retention Bonus or any repayment. |
12. | Acceptance. Please sign and return this Letter confirming your acceptance of its terms. This Letter may be signed in counterparts and electronically. |
Sincerely,
NETLIST, INC. | | |
| | |
By: | /s/ Chun K. Hong | |
Name: Chun K. Hong | | |
Title: President and Chief Executive Officer | | |
ACCEPTED AND AGREED: | | |
| | |
/s/ Gail Sasaki | | |
Gail Sasaki | | |
Date: November 6, 2026 | | |
Page 5
Exhibit 31.1
CERTIFICATION
I, Chun K. Hong, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Netlist, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:November 10, 2026 | /s/ Chun K. Hong |
| Chun K. Hong |
| President, Chief Executive Officer and Director |
Exhibit 31.2
CERTIFICATION
I, Gail Sasaki, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Netlist, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:November 10, 2026 | /s/ Gail Sasaki |
| Gail Sasaki |
| Executive Vice President and Chief Financial Officer |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Netlist, Inc., a Delaware corporation (“Netlist”) for the quarter ended September 26, 2026, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), each of the undersigned officers of Netlist certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of such officer’s knowledge:
| (1) | the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Netlist. |
Date:November 10, 2026 | /s/ Chun K. Hong |
| Chun K. Hong |
| President, Chief Executive Officer and Director |
| |
| |
Date:November 10, 2026 | /s/ Gail Sasaki |
| Gail Sasaki |
| Executive Vice President and Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to Netlist and will be retained by Netlist and furnished to the Securities and Exchange Commission or its staff upon request.